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Abstract 
Background: Diabetic kidney disease (DKD) is a serious chronic complication of diabetes, 
associated with increased risk of cardiovascular disease, end stage kidney disease and 
mortality. Intensive management, incorporating dietary and lifestyle changes with 
pharmacological agents, has been shown to reduce associated risks of DKD. This requires 
multiple self-management (SM) actions to optimise risk factors including diabetes, 
hypertension and hyperlipidaemia. Diabetes structured education (DSE) is integral to 
diabetes management and research shows DSE is beneficial to knowledge, SM activities, 
and diabetes control (Dekain et al., 2009; Speight et al., 2010). However, little evidence 
exists in DSE focused on DKD, despite the increased risk of mortality associated with the 
condition and NICE guidelines (NICE, 2008; NICE, 2003) encouraging education to 
optimise management of diabetes and kidney disease.  
Research aims:  To determine whether complication-specific DSE for DKD has an impact 
on SM, self-efficacy (SE), and knowledge related to DKD, and to identify what effect 
education has on participants. 
 
Methods: A mixed method approach, combining quantitative questionnaires and semi-
structured qualitative interviews was utilised. A standalone education module specifically 
for adults with DKD was provided for participants, tailored to the needs of this distinct 
group. 
 
Results:  A single education module demonstrated positive changes in SM activities, 
specifically seeking information, asking questions regarding biomedical results and 
following suggestions to alter dietary and exercise habits.   Improvements were also seen 
in knowledge related to DKD. Significant positive correlations were demonstrated between 
 
 
SM and SE outcomes related to seeking support and discussing worries with family and 
friends. Qualitative results identified that social support can have a negative or positive 
impact on participants depending on the nature of the support. It was also found that 
participants felt healthcare professionals did not inform them of their biomedical results.  
 
Conclusion: An education module specifically for DKD allows the information to be 
tailored to meet the needs of participants to a greater extend, which is in keeping with 
NICE guidelines (NICE, 2003). A single education session had a positive impact on 
participants demonstrated by improvements in DKD knowledge, SE and increased 
engagement in SM activities. Healthcare professionals can improve partnership with 
patients through the sharing of, and the significance of, biomedical information. This could 
have a benefit in reducing the health burden of DKD considering its morbidity and mortality 
risk.   
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1. Introduction 
1.1 Impact of Diabetes 
Diabetes Mellitus (diabetes) is a serious chronic metabolic condition characterised by 
elevated levels of circulating blood glucose, hyperglycaemia. The two most common 
variants of diabetes are Type 1 diabetes (T1DM) and Type 2 diabetes (T2DM) which are 
characterised as a total lack of the pancreatic hormone, insulin, as in T1DM and a relative 
lack of insulin or ineffective use of insulin by the body as in T2DM. Both conditions result in 
an inability to maintain normal glycaemic control (World Health Organization (WHO), 
2011).  
Long term suboptimal management of diabetes results in hyperglycaemia leading to 
structural damage to cells and alterations to normal metabolic processes. These 
alterations are associated with development of microvascular and macrovascular 
complications of diabetes and increased atherosclerosis risk   (Fowler, 2008; Williams & 
Pickup, 1999). The extent of hyperglycaemia is directly associated with an increase in the 
risk of developing secondary complications, particularly the microvascular complications 
nephropathy, retinopathy, and neuropathy, affecting the eyes, kidneys and nerves 
respectively (Stratton et al., 2000). 
 
1.2 Diabetic kidney disease 
 The umbrella term diabetic kidney disease (DKD) is used to describe CKD in the 
presence of diabetes whether it is a direct result of diabetes (diabetic nephropathy) or from 
vascular complications which often accompanies diabetes. 
Development of CKD is substantially increased in those with diabetes in comparison to the 
general population, with an eight and twelve fold increase observed for women and men 
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with diabetes, respectively (Hippisley-Cox &Coupland, 2010). The prevalence of DKD 
varies from 18% to 30% across the UK, with variation attributed to ethnicity, age and level 
of deprivation (Diabetes Kidney Care, 2011). The impact of the condition is impaired 
kidney function, which can deteriorate to end stage kidney disease (ESKD). DKD is the 
leading cause of ESKD in the UK, with 21.9% of all cases attributed to the condition 
(Farrington, Udayaraj, Gilg, & Feehally, 2009). 
Research has demonstrated that the risk of developing the detrimental effects of diabetes, 
such as DN can be reduced with appropriate long term management of diabetes and 
cardiovascular risk markers (Diabetes Control and Complications Trial [DCCT], 1993).   
 
1.3 Diabetic kidney disease management 
The National Institute of Clinical Excellence (NICE) states that approaches to delay or 
prevent the progression of CKD to end stage kidney failure are warranted (NICE, 2008) 
and have set out national guidelines in the areas of both diabetes (NICE, 2003) and 
chronic kidney disease (NICE, 2008) for the appropriate management of the conditions. 
Intensive treatment targeting hyperglycaemia, dyslipidaemia, hypertension and 
microalbuminuria has been shown to slow the progression of diabetic kidney disease 
(Gaede, Vedel, Parving, & Pedersen, 1999).  Therefore interventions which aid a reduction 
in these clinical indicators of risk must be a priority in order to reduce the impact of DN.  
Recommendations are set out in both guidelines calling for high quality programmes to 
educate patients and enable them to make informed decisions about their care in 
partnership with healthcare professionals (NICE, 2003; NICE, 2008).   
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1.4 Structured Education: Diabetes & CKD  
The National Institute of Clinical Excellence (NICE) recommends that the National Health 
Service (NHS) provides structured education for all people with diabetes (NICE, 2003). 
NICE (2003) advise that such education should be adapted to the needs and personal 
choices of the individual.  
There is a wealth of research on the benefits of diabetes structured education (DSE) 
(Davies, et al., 2008; Deakin, Cade, Williams & Greenwood, 2006; Deakin, McShane, 
Cade & Williams, 2009), however a clear lack of educational interventions in the earlier 
stages of CKD has been identified, which may have the benefit of reducing the 
progression of the condition (Byrne et al., 2011). Current CKD education tends to focused 
on individuals in the pre-dialysis or dialysis stage   (Li et al., 2011; Mason, Khunti, Stone, 
Farooqi, & Carr, 2008). Moreover, there is a lack of research, which potentially reflects a 
lack of education, in the area of specific education tailored to the management of DKD, 
which would combine the education needs of managing two chronic conditions.  
Taking this into consideration, the provision of education which combines diabetes and 
CKD self-management (SM), in the form of modular education specifically for DKD could 
meet NICE recommendations (NICE, 2003) more thoroughly, tailoring the content and 
allowing for greater flexibility to meet the needs of this distinct group. The potential exists 
for this type of tailored education to improve the outcomes of individuals with DKD. 
 
1.5 The Research Proposal  
This current study will look at the effects that the education module “Diabetes Essentials: 
Kidneys” has on knowledge, SE, and SM. It will combine these outcomes with qualitative 
research findings to gain an understanding about the participant’s experience of education 
and its impact on their self-care practice. Research into the role of education in the 
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management of DKD and its impact on individuals with the condition will be examined. The 
study aims to identify the associations between the complex outcome measurements and 
explore the effects of education specifically for a population with DN.  
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2. Literature Review 
 
2.1 Diabetic Kidney Disease 
2.1.1 Pathophysiology of Diabetic Kidney Disease 
It is accepted that the pathophysiology of DKD in T1DM and T2DM is very similar (Wolf, 
2004). CKD is defined as a reduction in glomerular filtration rate (GFR) or kidney damage 
for three months or longer (Levey et al., 2003). GFR is the best measure of overall kidney 
function in health and disease (Levey et al., 2003) and estimated GFR (eGFR), calculated 
using serum creatinine levels is the manner in which GFR should be measured routinely 
(NICE, 2014).   
One of the earliest indications of CKD is damage to blood vessels in the functional cells of 
the kidneys i.e. the glomerulus capsule, disrupting the normal filtration ability of the kidney 
(Satchell & Tooke, 2008). During DKD, excess circulating blood glucose combines with 
proteins forming irregular compounds known as advanced glycosylated end products 
which are deposited in the glomeruli causing the vascular cell lining to thicken and disrupt 
normal cellular activity (Sego, 2007). Combined with this, a change in capillary pressure in 
the glomeruli causes hyperfiltration and hyperperfusion which again leads to thickening of 
the cell lining (Wolf, 2004). Hypertension and hyperlipidaemia, two common accompanying 
conditions in diabetes, exacerbate the damage to the vascular cells (Sego, 2007; Hovind, 
Rossing, Tarnow, Smidt, & Parving, 2001). Other compounds implicated in kidney decline 
are explained extensively in other literature (Wolf, 2004; Satchell, & Tooke, 2008).  
 
The change in the structural integrity of the glomeruli disrupts its normal functioning and 
generally results in albumin, a protein which should be retained in the blood during 
9 
 
filtration, passing through the kidneys, in a condition known as microalbuminuria 
(Satchell& Tooke, 2008). Persistent microalbuminuria is a clinical marker of DKD 
development, as it is a risk factor for the progression to macroalbuminuria (or proteinuria) 
which is a characteristic of overt DKD (Hovind, Rossing, Tarnow, Smidt, &Parving, 2001; 
Satchell& Tooke, 2008). Proteinuria precipitates a fall in the filtration rate of the glomeruli 
and therefore kidney function decline (Levey et al., 2003). Continued decline in GFR 
causes progression of DKD with deterioration to end stage kidney disease (ESKD). 
 
Microalbumiuria is not a prerequisite to DKD progression and absence of microalbuminuria 
is common in older adults with T2DM presenting with other vascular problems (Hill, & 
Fogarty, 2012).  This population present with the glomerular changes, alongside ischemic 
and vascular changes which results in a fall in GFR in the absence of albuminuria (Hill, & 
Fogarty, 2012).  
 
Evidence emphasises that progression from microalbuminuria to proteinuria is not an 
absolute. In T1DM population studies, 58% of microalbuminuria cases returned to 
normoalbuminuria (Perkins, Ficociello, Silva, Finkelstein, Warram, & Krolewski, 2003) and 
in a second study, only 30-45% of individuals with microalbuminuria progressed to 
proteinuria over a ten year period (Gross, de Azevedo, Silveiro, Canani, Caramori, & 
Zelmanovitz, 2005). This regression or lack of progression was a result of improved 
management of glycaemia, hypertension and hyperlipidaemia (Gross, de Azevedo, 
Silveiro, Canani, Caramori, & Zelmanovitz, 2005; Perkins et al., 2003).  
 
The implication of the condition leads to a substantial impact on the individual as well as 
health services.  
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2.1.2 Health burden of diabetic kidney disease  
DKD is a serious chronic condition with associated complications including hypertension, 
anaemia, renal bone disease, hyperkalemia, hyperphosphatemia, and ESKD (Diabetes 
UK, 2013; Levey et al., 2003).  
Estimated prevalence of DKD range from 33-45% for those with T1DM (Nathan, 1993; 
Satchell& Tooke, 2008) and 20-30% for those with T2DM (Nathan, 1993; Department of 
Health [DoH], 2006). It is the leading cause of ESKD in the UK accounting for 24% of all 
ESKD diagnoses (Gilg, Castledine & Fogarty, 2012). Of those who require renal 
replacement therapy (RRT), 14% of cases are due to DKD (Gilg, Castledine & Fogarty, 
2012). The progression to the point of RRT is pertinent in view of the increased risk of 
mortality (Foley et al., 2005). 
ESKD has an approximate mortality rates of 15-20% per year for the whole population and 
results in a mortality rate one hundred times greater among those receiving RRT than the 
general population (Walker & Buchbinder, 2012). For those with diabetes receiving RRT 
the mortality rates are substantially higher indicated by an a threefold increase risk  those 
over 85 years of age and a 25 fold increase for those aged 30 to 34 years compared to the 
general population (Steenkamp, Castledine & Feest, 2012).  
A substantial burden of DKD is the association with CVD (Diabetes UK, 2013; Levey et al., 
2003). Independently, microalbuminuria is a strong indicator of vascular disease risk 
(NICE, 2008) while impaired GFR in T1DM is associated with increased risk of coronary 
artery calcification and in T2DM with increased CVD (de Ferranti et al., 2014). 
 
NHS Kidney Care & NHS Diabetes (2011) identifies CVD as the most common 
complication of diabetes, however acknowledges DKD as the most severe diabetes 
complication (Levey et al., 2003). For those with CKD, death from CVD is more likely than 
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from CKD directly (Levey et al., 2003; Sarnak et al., 2003).  One study demonstrated 
incidence rates of RRT of 3.4 per 100 patient years, compared to death rates of 19.9 per 
100 patient years in those with DKD (Foley, Murray, Li, Herzog, McBean, Eggrs & Collins, 
2005). In this same study rates of congestive heart failure and myocardial infarction in 
DKD were 52.3 and 6.9 per 100 patient years respectively, which when compared to rates 
of RRT, emphasises the higher rates of CVD over RRT in DKD (Foley et al., 2005). 
In summary, the increased prevalence of CKD in those with diabetes, the associated 
significant health burden and increased mortality substantiate the need for appropriate 
management of affected individuals, and efforts to delay and prevent progression to 
ESKD. 
 
2.1.3  Quality of Life 
Diabetes carries a substantial self-management burden, combining alterations to lifestyle 
to manage the condition, dealing with short term complications and potentially long term 
consequences (Polonsky, 2000). Diabetes reduces quality of life (QoL) below that of age 
matched people without diabetes (0.76 versus 0.80 respectively) (Koopmanschap, 2002). 
Moreover QoL reduces with the onset of secondary complications of diabetes (0.69) and 
reduced further with the presence of both a macro- and micro-vascular complication (0.59) 
(Koopmanschap, 2002).  
 
There is limited research into QoL in patients with CKD, particularly prior to ESKD, and 
even less so in DKD specifically. The evidence available suggests people with DKD have 
a lower QoL score than those with CKD without diabetes and this reduces further with 
increasing duration of DKD (Diabetes Kidney Care, 2011). This reduction is an important 
consideration of individual management, in combination with the clinical manifestations of 
the condition.  
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2.1.4 Cost of diabetic kidney disease  
Diabetes is accompanied by a considerable cost implication, with an estimated £23.7 
billion or 10% of the total National Health Service (NHS) budget spent on diabetes in the 
2010/11 financial year (Hex, Bartlett, Wright, Taylor & Varley, 2012).  Direct cost of 
diabetes incorporates diagnosis and treatment of diabetes and diabetes complications, the 
latter of which has the most significant financial burden of the disease entity, accounting 
for 80% of the direct costs (Hex et al., 2012). This financial burden is predicted to rise as a 
result of the continuing rise in the incidence diabetes and the aging population (Hex et al., 
2012). 
CKD carries a lesser yet substantial cost burden also, of approximately £1.45 billion in 
England during 2009/10, which accounted for approximately 1.3% of NHS spending (Hill & 
Fogarty, 2012). More than half of this spending is implicated in RRT, which is required for 
only 2% of the CKD population (NICE, 2014).  
The number of people in ESKD receiving RRT is growing and propose reasons for this, 
outlined by Hill & Fogarty (2012) are:  
 Increasing prevalence of diabetes which in turn increases rates of CKD and ESKD 
 Primary care incentives to identify and manage DKD, leading to increased and 
earlier management and initiation of treatment  
 Increased incidences of ESKD as a result of improved management of 
cardiovascular risks and reduced mortality as a result 
 Greater availability of the service, particularly for those with diabetes, who 
historically faced greater restrictions in RRT. 
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Improved service delivery to reduce the cost implication of managing ESKD is advisable 
(Kerr et al., 2012). Approximately £470 per patient could be saved when appropriate 
management of hypertention and proteinuria is provided over five years (Kerr et al., 2012). 
This saving relates to earlier management of CKD in order to reduce progression to ESKD 
and also reductions in myocardial infarction and stroke risk (Kerr et al., 2012).  
It can be concluded that appropriate management of diabetes and its complications are 
essential in order to improve outcomes, life expectancy, QoL and the associated financial 
burden. 
 
2.2 Management of diabetic kidney disease 
Earlier it was indicate that optimal management of risk factors reduces the risk of DKD, 
can reverse the earliest indications of the condition and subsequently delays progression 
of DKD. This is supported by guidelines which encourage early intervention to reduce the 
health burden of DN (Levey et al., 2003; NICE, 2004; NICE, 2009).  
Evidence from the Diabetes Control and Complications Trial (DCCT) shows a reduction in 
glycated haemoglobin (HbA1c), the clinical marker of diabetes control, to less than 
53mmol/mol, through intensive management is associated with an approximate 60% 
reduction in the risk of development or progression of microvascular complications 
compared to those with a HbA1c greater than 75 mmol/mol (DCCT, 1993). The DCCT 
found that intensive diabetes management in T1DM reduces the risk of microalbuminruria 
and proteinuria by 39% and 54% respectively (DCCT, 1993). The UK Prospective 
Diabetes Study (UKPDS) of intensive diabetes control in T2DM found that achieving an 
11mol/mol (1%) reduction in HbA1c is associated with a 37% risk reduction in 
microvascular disease including DN (Stratton et al., 2000). 
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Large multi-centred multi-national randomised control trials have demonstrated that 
intensive therapy utilizing pharmacological agents and lifestyle education in the 
management ofHbA1c, hypertension and dyslipidaemia has been shown to be effective in 
reducing microalbuminuria (The ACCORD Study Group, 2008; DCCT, 1993). The 
ADVANCE Collaborative Group (2008) demonstrated a significant 86% reduction in DKD 
development with such intensive interventions.  
 The Steno-2 study was a multi-factorial approach combining lifestyle and behavioural 
changes with pharmalogical interventions incorporating optimisation of glycaemia, blood 
pressure (BP) and dyslipidaemia (Gæde et al., 2003). The study observed a 61% risk 
reduction in the development or progression of DN when HbA1c was targeted to less than 
48mmol/mol, cholesterol to less than 4.5mmol/L, triglycerides to less than 1.7mmol/L and 
BP to less than 130/80 mmHG (Gæde et al., 2003). This shows the benefits of optimising 
risk factor control in the management of DKD. 
The ACCORD study is notably in this area due to its early termination as a result of 
increased all-cause mortality (The ACCORD Study Group, 2008). Due to the increase, the 
intensive glycaemia cohort (targeting HbA1c <42mmol/mol) transitioned to standard 
treatment (targeting HbA1c 53-63mmol/mol) Although a definitive explanation for this 
increase has not been established, a number of factors have been proposed, including 
greater weight gain, higher rates of severe hypoglycaemia, greater levels of anti-
hyperglycaemic agents and potentially drug interactions (Ismali-Beigi et al., 2010; Skyler et 
al., 2009). In terms of the impact on kidney function, there was an unexpected greater 
reduction in eGFR as a result of intensive diabetes management within the first 24 months 
(Ismali-Beigi et al., 2010). It is proposed that this decline may have been as a result of 
improved glycaemia causing an increase in glomerular hyperfiltration which would be 
represented by a fall in eGFR (Ismail-Beigi et al., 2010). Reduction in GFR does occur in 
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the early stages of DKD as a result of hyper-function and hypertrophy before stabilising 
(Mogensen, Christensen, & Vittinghus, 1983).  
Despite the differences in eGFR at transition (3.7 years), there was no difference at the 
end of the study period (5 years) (Ismali-Beigi et al., 2010).This study did identify 
improvements in micro and macro- albuminuria development which was significantly 
reduced (21% and 31% respectively) at the end of the intensive treatment phase (3.7 
years) (Ismali-Beigi et al., 2010). This reduction was attenuate (15% & 27% respectively) 
however maintained significance at the end of the 5 year study period (Ismali-Beigi et al., 
2010).  
 No difference in the levels of ESKD was found between intensive and standard care 
(Ismail-Beigi, et al., 2010). However it is acknowledged that the observation period (5 
years) may not have been sufficient for such long term outcomes to become evident. In a 
longer follow-up period of ten years, the UKPDS study demonstrated cardio- and micro-
vascular benefits persisted or increased from interventions to optimise control (Holman, 
Paul, Bethel, Matthews & Neil, 2008).    
The overall consensus is that optimising glycaemic control is important for risk reduction; 
however it should be considerate of individuals and targets tailored as such (Ismali-Beigi et 
al., 2010; Skyler et al., 2009). Targeting HbA1c to less than 42 mmol/mol as achieved in 
the ACCORD study is not warranted and is unsafe practice (Ismali-Beigi et al., 2010).  
As mentioned, factors, other than glycaemia, namely hypertension and dyslipidaemia are 
implicated in the progression to ESKD and are important considerations in the overall 
management of diabetes, particularly given the associated increased CVD risk (ADVANCE 
Collaborative Group, 2008; Gæde et al., 2003; Hovind et al., 2001; Ismail-Beigi et al., 
2010). Studies support, the prioritising of BP management in DKD in particular (Wolf & 
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Ritx, 2003; Levey et al., 2013) targeting 130/80 mmHg in order to maximise the protective 
cardiovascular effect (Wolf & Ritz, 2003; Ruggenenti, Schieppati, & Remuzzi, 2001).  
 
The evidence advocates and NICE guidelines support effective management of risk 
factors in order to reduce the risk of developing DKD and reduce the progression of ESKD 
(ADVANCE Collaborative Group, 2008; DCCT, 2003; Gæde, Vedel, Parving, & Pedersen, 
1999; NICE, 2008).   
 
2.3 Dietary management in diabetic kidney disease 
Lifestyle management is a key factor in DKD. One study showed that the management of 
risk factors in those with T2DM and microalbuminuria reduces CVD risk, such that 
treatment of 5 people for 8 years would prevent one CVD event (Gaede et al., 2003).  
The Steno-2 study demonstrated improved DKD management utilising pharmacological 
agents alongside behavioural change strategies and education to control biomedical risk 
factors (Gæde et al., 1999).  
 
2.3.1 Glycaemic control  
The DCCT trial which identified the importance of glycaemic control in reducing the risk of 
developing diabetes complication, incorporated nutritional behaviours associated with a 
reduction in HbA1c of 4-11 mmol/mol (Delanhanty & Halford, 1993). This study identified 
appropriate hypoglycaemia treatment, adjustment of insulin for food intake, limiting 
additional supper snacks and additional insulin to treat hyperglycaemia as dietary factors 
aiding improvements of HbA1c in T1DM (Delanhanty & Halford, 1993).  This role of the 
diet in managing diabetes control is supported by the “dose adjustment for normal eating” 
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(DAFNE) research, which identifies the positive effective matching insulin to carbohydrate 
amounts, reducing HbA1c by 11.0mmol/mol at six months and 3.6 mmol/mol reduction at 
44 months (Speight et al., 2010). This management regime is recommended for those with 
T1DM and on multiple daily insulin regimes while standardised carbohydrate portions for 
those with T1DM on fixed insulin regimes is recommended (Dyson et al., 2011). Diabetes 
UK evidenced based guidelines for the management of T2DM diabetes encourages weight 
management, physical activity, standardising carbohydrate intake and potentially the use 
of low glycaemic index foods as beneficial in aiding glycaemic control in T2DM (Dyson et 
al., 2011).  
2.3.2 Hypertension 
Hypertension causes an increase in capillary pressure in the glomeruli of the kidneys 
which causes damage and thickening of the glomerular cell lining which aids the 
development and progression of DKD (Hovind et al., 2001; Sego, 2007; Wolf, 2004).  
Lifestyle modification to aid blood pressure control is warranted as a major aspect of HTN 
management (ADA, 2002). NICE (2011) encourage reductions in excessive alcohol intake, 
reducing excessive caffeine intakes and offering guidance on healthy eating, exercise and 
smoking cessation. 
Dietary factors other than sodium have been implicated in the optimisation of BP. The 
Dietary Approaches to Stop Hypertension (DASH) study (1997) identified a significant 
reduction in BP through dietary measures which combined increased fruits, vegetables 
and low fat dairy and reduced intake of total fat, saturated fat and cholesterol. The diet 
therapy followed for an eight week period resulted in a statistically significant BP reduction 
of 11.6/5.3 mm Hg (P<0.001) in individuals with hypertensive (Svetkey, 1999). 
The reduction in BP demonstrated in the DASH population is comparable to those with 
mild HTN requiring monotherapy (Svetkey, 1999). The beneficial effect of this therapy on 
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BP reduction is increased as baseline BP increases which encouraged dietary 
interventions, in conjunction with pharamalogical agents in the optimisation of therapy to 
manage those more hypertensive individuals (Svetkey, 1999). 
 
2.3.3 Dyslipidaemia  
Hyperlipidaemia is implicated in the progression of DKD due its effect in exacerbating the 
damage to the vascular cells (Sego, 2007). Appropriate management of hyperlipidaemia is 
important in the increased CVD risk in addition to DKD management. The Joint British 
Societies’ (JBS) guidelines suggest targeting treatment to optimise total cholesterol to less 
than 4.0 mmol/l and LDL cholesterol to less than 2.0 mmol/l or 25% and 30% reduction 
respectively, whichever has the biggest reduction (Wood, Durrington, & Poulter, 2005). 
The Steno study showed beneficial effects in reducing the progression of DKD in T2DM 
and involved dietary intervention as well as optimisation of medication (Gaede et al., 
2003). This study showed statistically significant reduction in total cholesterol, LDL 
cholesterol and triglycerides (0.6, 0.4 and 0.5 mmol/l respectively) with no significant 
change in HDL-cholesterol (Gaede et al., 2003).  This aim of dietary intervention for this 
intervention involved targeting total daily intake of fat to less than 30% and saturated fat to 
less than 10% (Gæde et al., 1999).  
Similarity exist with NICE guidelines, which advises those with or at high risk of CVD 
(which includes those with diabetes) to restrict total fat to 30% or less of total energy 
intake, saturated fat to 7% or less, dietary cholesterol to less than 300 mg/day and for 
monounsaturated and polyunsaturated fats to replace saturated fats where possible. 
 
19 
 
In conclusion, glycaemic control, hypertension, and dyslipidaemia are all areas where 
dietary and lifestyle behaviour have an impact (NICE, 2004; NICE, 2009; Dyson et al., 
2011) and therefore should be encouraged in those with DKD.  
 
2.4 Chronic disease self-management  
 
Long term conditions (LTCs) have become the biggest health burden facing health service 
provider globally (Barrett 2012). LTCs include diabetes, CKD, CVD, chronic obstructive 
pulmonary disease and cancers. Not only are incidences of these conditions rising 
individually, there is also a greater number of people living with more than one chronic 
disease. Barrett et al., (2012) reports of those with a LTC in Scotland, approximately 40% 
are living with two LTCs and 23% with two or more conditions.  
 
Each LTC will have individual priorities in terms of lifestyle and dietary management  and 
medication regimes, which lends itself to the proposal that healthcare strategies which 
incorporate the management of multiple LTCs will improve clinical care (May, Montori & 
Mair, 2009). Strategies which effectively support people with self-managing their 
conditions by aiding the combination of LTCs management plans, will aid the burden on 
individuals, and  may lead to greater adherence to medical advice and as result improve 
the cost effectiveness of health service input (May et al., 2009).  
 
As mentioned earlier the prevalence of CKD increases in those with diabetes, therefore 
strategies which incorporate the self-management (SM) of both conditions could be 
beneficial. Research into SM strategies in this area is outlined below.  
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2.4.1 Diabetes structured education 
Structured education for the management of diabetes is considered best clinical practice in 
order to provide individuals with the empowerment to manage their condition (NICE, 
2003). The aim of DSE is to improve knowledge and skills, enable people with diabetes to 
take control of their condition and to implement SM of the condition into daily living (NICE, 
2003).   
Numerous studies have reported the benefits of education in the area of diabetes (Deakin, 
McShane, Cade, & Williams, 2005; Ellis, et al., 2004; Norris, Lau, Smith, Schmid, & 
Engelgau, 2002) but there is a lack of research focused specifically on the effect of 
education in the area of development or progression of secondary complications.  
A meta-analysis has shown that DSE has a beneficial effect on HbA1c and BP (Deakin, 
McShane, Cade, & Williams, 2005). Both these outcomes reduce risk of DKD (ADVANCE 
Collaborative Group, 2008; Ismail-Beigi et al., 2010) and progression to ESKD (Gæde et 
al., 2003). A limitation of DSE research is the lack of evidence in end point outcomes such 
as ESKD or mortality, however it is acknowledged that further research is needed in this 
area (Deakin et al., 2005).   
Conflicting evidence exist as to whether DSE, can lead to an improvement in diabetes 
control measured by HbA1c, which clinically would be the desirable outcome given the 
relationship between this clinical marker and complications and mortality (DCCT, 1993). 
Some education studies have shown an improvement in HbA1c (Davies et al., 2008; 
Deakin, Cade, Williams, & Greenwood, 2006) while others have demonstrated 
improvements in knowledge, SE and self-management outcomes (Deakin et al., 2005).  
Knowledge is a vital factor for education as people require information in order to 
understand their condition and how their daily lifestyle impacts on its management. 
Without this knowledge, people have no awareness or reason to change behaviours 
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(Mason, Khunti, Stone, Farooqi, & Carr, 2008). In theory, people require increased 
knowledge to improve management of their condition, however improved knowledge 
through DSE has not been shown to result in improved biomedical outcome measures 
(Gomersall, Madill, & Summers, 2011; Steed et al., 2005), unless the actual principles of 
education are implemented and maintained by the individual (Gomersall et al., 2011). This 
lack of improvement in HbA1c is potentially due to a lack of the new knowledge required to 
inform the necessary behaviour changes required to effectively manage HbA1c. Also given 
the progressive nature of diabetes, which is reflected in the need for frequent medical 
reviews and treatment progression (Koopmanschap, 2002), deterioration in HbA1c can 
occur when effective strategies for SM are not revised or implemented. This emphasises 
the need for partnership between health services and patients which is encouraged for 
diabetes management (NICE, 2003; DoH, 2010).  
Educational interventions have found that those who had a greater understanding of the 
terminology and clinical markers of diabetes and CKD risk factors were those who 
implemented dietary SM behaviours to a greater degree (Beard, Clark, Hurel, & Cooke, 
2010; Goron & Lash, 2011). This suggests that explaining and sharing information 
regarding clinical markers is beneficial to improved care.  
Evidence supports the idea that factors other than knowledge are also implicated in 
behaviours for diabetes SM (Beard et al., 2010; Knight, Dornan, & Bundy, 2006). DSE will 
only impact outcomes if behavioural changes are implemented (Knight et al.,  2006; Curtin, 
Walters, Schatell, Pennell, Wise, & Klicko, 2008). Therefore, although knowledge may be 
a pre-requisite of instigating behavioural change, other factors such as a person’s 
confidence in their capabilities to implement changes or their feeling of self-efficacy (SE) 
(Sturt, Hearnshaw, & Wakelin, 2010). Also the motivation or willingness they have to 
change habitual daily living tasks in order to improve SM is of importance (Curtin et al., 
2008). However, behavioural changes to optimise diabetes control are acknowledged to 
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be challenging for individuals to instigate and maintain (Funnell & Anderson, 2004). This is 
particularly the case when behavioural changes are not considerate of an individual’s own 
priorities, goals, or daily routine (Funnell & Anderson, 2004). 
Self-determination is required by the individual in order to implement behavioural changes 
which itself is a complex process influenced by motivation, knowledge, beliefs, attitude and 
social support (Al-Khawaldeh, Al-Hassan, & Froelicher, 2012). The ability to instigate the 
necessary behavioural changes is thought to be related to an individuals’ feeling of SE, 
which is the extent to which a person believes they have the ability to carry out tasks to 
accomplish goals (Bandura, 1997). Therefore making behavioural changes requires 
multifaceted actions combining knowledge with the SE to implement SM actions and this is 
influenced by the personal factors mentioned above.  It is proposed that the areas of 
knowledge, SM skills and SE are all required in order for progress in improving HbA1c (Al-
Khawaldeh et al., 2012).  
For these reasons, it is understandable that intensive multifactorial interventions 
incorporating tailored education have been advocated in this area (Gæde et al., 2003). 
 
2.4.2 Chronic kidney disease self-management 
Similar to diabetes, it is well accepted that SM is required to manage CKD (Al-Khawaldeh, 
Al-Hassan, & Froelicher, 2012; Costantini, Beanlands, McCay, Cattran, Hladunewich & 
Francis, 2008; Li, Wu, Wang, Huang, Yang, Dong, & Liu, 2011; NICE, 2003). For reasons 
of practicality, logistics and financial burden, the management of CKD cannot be achieved 
by input solely from health professionals but necessitates the individual’s SM on a regular 
basis for the vast majority of management actions (Costantini, et al., 2008; Curtin, Walters, 
Schatell, Pennell, Wise, & Klicko, 2008). This involves the ability to change and sustain 
behaviours in relation to diet, physical activity, medication, self-monitoring and attendance 
at medical review (Li et al., 2011; Costantini, et al., 2008). 
23 
 
 
In the area of CKD the provision of education or information is recommended in order for 
individuals to “fully understand and make informed decisions about their treatment” (NICE, 
2008 p15) and should be considerate of what the condition is, how the person can manage 
their condition and the treatment options (NICE, 2008).   
 
2.4.3 What is effective in education for CKD? 
A systematic review of randomised control trials (RCTs) involving educational interventions 
in CKD  (not specifically for DKD) found that a once only group education session 
supported with written information resulted in short term significant improvements in SE 
and self-care dialysis knowledge (Mason, Khunti, Stone, Farooqi, & Carr, 2008). This 
education was specifically targeting people in the pre-dialysis with CKD Stages 4 and 5 
who were attending for pre-dialysis care. Positive outcomes were also reported in long 
term follow-up studies with improvements in knowledge retention, delayed onset of dialysis 
therapy and greater survival rates at 20 years (Mason et al., 2008).  
 
A systematic review was unable to identify RCT’s of educational intervention in CKD 
Stages 1 to 3 which were of sufficient quality for inclusion in the review (Mason et al., 
2008). An important consideration highlighted by the authors is that the lack of educational 
interventions in the early stages of CKD may be associated with a high level of late 
referrals to specialist renal services (Mason et al., 2008). This may be due to a lack of 
awareness in general practice with regards to deteriorating kidney function and the 
benefits of referral to a specialist renal team and early intervention. Mason et al., (2008) 
stipulate that an increase in public awareness of CKD is warranted combined with 
preventative education. They suggest that ‘a structured intervention aimed at empowering 
patients with the knowledge, skills, and motivation to help control their blood pressure and 
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lead healthier lifestyles could help prevent or delay the progression of kidney disease’  
(Mason et al., 2008, p.949). This was based on a systematic review of interventions which 
aimed to increase knowledge and motivation, predominantly through individual interactions 
with pre-dialysis and dialysis patients (Mason et al., 2008). Improvements in a variety of 
outcomes including SM, reported SE and knowledge at four weeks were reported as well 
as increased survival (median 2.25 years) at twenty years (Devins, Mendelssohn, Barré, 
Taub, &Binik, 2005) and delayed onset of 4.6 months for dialysis (Binik et al., 1993).  
The long term outcomes trials examined individual educational intervention as opposed to 
group education sessions however the finding are promising in terms of benefit for those 
with CKD (Devins et al., 2005). Mason et al., (2008) recognises that there is limited 
evidence of the use of education intervention in areas of CKD management, with the 
majority concentrated on the dialysis stage and concordance with dietary and fluid 
recommendations (Mason et al., 2008) 
 
Mann et al., (2008) supports the use of a small group standalone session to improve 
outcomes in those in the pre-dialysis stage, suggesting session should be interactive, use 
problem based learning and be supported with written information (Mann et al., 2005). This 
has been shown to be effective in improving knowledge, SE and in this population, the 
willingness to start self-care dialysis (Mann et al., 2005).   
 
2.4.4 Education in diabetic kidney disease 
There is a clear lack of evidence in the area of DKD education (Li, Wu, Wang, Huang, 
Yang, Dong, & Liu, 2011) although studies in diabetes and CKD independently 
acknowledge the benefits of such an approach in the management of each condition 
(Deakin et al., 2005; Mason et al., 2008). It is also acknowledge that although diabetes is a 
major cause of CKD, a distinct lack of research exists in the area of DKD (Li et al., 2011) 
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and potentially reflects a lack of structured education as routine practice in the area. 
Studies which incorporate individuals with DKD do not distinguish DKD from CKD or 
alternatively were not educational only interventions rather were combined with 
pharmacological therapy (Li et al., 2011).  
 
In a Cochrane systematic review of education programmes specifically for people with 
DKD (Li et al., 2011), one study examined the effects of education in the early stages of 
DKD (Steed, Lankester, Barnard, Earle, Hurel, & Newman, 2005). Steed et al., (2005) 
examined the effects of a DSE program over three months versus routine care in a group 
of individuals with T2DM and microalbuminuria. Attendance at the education session 
showed significant improvements in diabetes knowledge, self-reported dietary behaviours, 
exercise and blood glucose monitoring immediately post intervention (week 5) and 
additionally at three month follow-up for all these with the exception of dietary behaviours. 
In respect of dietary behaviours, although these were significantly improved immediately 
post intervention; by three months this had declined and were no longer significantly 
different from the control group (Stead et al., 2005). This suggests that, as time from 
education elapses so too does the implementation of dietary behaviours. 
 
Participation in this course resulted in a 9% attrition rate at the end of the intensive phase 
(five weeks) and 17% at the three month course end, with a greater number lost in the 
intervention group (immediate post-intervention 4 participants control group, 9 participants 
intervention group; at 3-month follow-up 8 participants control group, 12 participants 
intervention group) (Stead et al., 2005). This has important implications when considering 
the manner in which education should be delivered, suggesting that greater time 
commitment results in greater reduction in attendance. This is an important consideration 
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of current strategies alongside exploration of the reasons for the higher attrition in the 
intervention group.  
Although the study shows that knowledge and SM behaviours are improved by education, 
this did not correlate with improvement in diabetes management as measured by HbA1c, 
which showed no difference from the control group at three month follow-up (Stead et al., 
2005).  This is consistent with other research in the area which indicates that although 
education positively impacts knowledge and self-reported SM behaviours, this is not 
reflected in improvements in diabetes control (Al-Khawaldeh et al., 2012; Davies et al., 
2008).  
 
As mentioned in a previous section, studies conflict on whether DSE affects HbA1c.  The 
X-pert education did show positive outcomes in HbA1c with DSE, with a statistically 
significant -5.5mmol/mol difference between the DSE group and control group (Deakin et 
al., 2006) This is at variance with the current study, however the X-pert study was over 
fourteen month study duration in comparison to Stead et al. (2005) which investigated a 
three month period. The measurement of HbA1c involves analysis of the lifespan of 
erythrocytes, representing 120 days (Rohlfing, Wiedmeyer, Little, England, Tennill, & 
Goldstein, 2002) therefore potentially studies of shorter duration are less likely to 
demonstrate a change in HbA1c due to a lack of time for SM changes to affect HbA1c.  
  
2.5 Outcome measures 
NICE guidelines on education suggest the relevant outcome measures of DSE are 
knowledge, motivation and anxiety or depression related to diabetes (NICE, 2003). 
Education has a positive impact on knowledge, and self-reported SM practices as well as 
feelings of SE in relation to SM (Deakin et al., 2005; Mason et al., 2008). However the 
majority of the research does not correlate these behaviour changes to improvements in 
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HbA1c (Davies et al., 2008; Deakin et al., 2005; Deakin et al., 2006) As stated previously 
HbA1c is the most popular measurement of successful treatment as it has been directly 
related to reductions in the risk of complications (DCCT, 1993) and as it is a clinically 
appropriate standardised measurement which reduces bias. Nonetheless a lack of chance 
in HbA1c should not result in education being viewed in a negative manner.  
As stated previously the progressive and changing nature of diabetes, as well as the 
multiple factors affecting effective management makes achievement of ideal HbA1c 
challenging. The challenge of achieving optimal HbA1c (below 58mmol/mol) is reflected in 
the fact that only 62.2% of the population with diabetes in England & Wales achieved this 
target (Health and Social Care Information Centre, 2014)   
 
A Cochrane review of DKD education, recognise that instigation and maintenance of 
behaviours for SM is required to support diabetes control and minimise the progression of 
DKD (Li et al., 2011). NICE clinical guidelines on the management of diabetes and the 
provision of education support knowledge development and implementation of SM (NICE, 
2003).  Studies in diabetes education and in CKD have looked at SM activities, knowledge 
and levels of SE in order to demonstrate the impact of education on outcomes (Al-
Khawaldeh et al., 2012; Curtin et al., 2008; Deakin et al., 2005; Stead et al., 2005). Use of 
these measures would allow for comparison and includes outcomes identified as important 
by NICE (2003).  
 
To conclude, education which provides greater personalisation of education to individuals 
needs aids the management of multiple LTCs. This should be considerate of the needs of 
specific population sub groups and provide specific disease related knowledge, and 
effective strategies to improve SE and the necessary skills for SM activities.  
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2.6 The research questions 
2.6.1 Aim of the project 
To determine whether a modular approach to diabetes education in the form of 
complication specific education for DKD has an impact on adults with the condition in 
terms of SM, SE and knowledge related to DKD and to identify what effect education has 
on participants. 
  2.6.2 Research questions 
 Does Diabetes Essentials: Kidneys affect self-reported SM activities in relation to 
DKD? 
 What effect does Diabetes Essentials: Kidneys have on self-reported SE? 
 What effect does Diabetes Essentials: Kidneys have on knowledge? 
 What effect does Diabetes Essentials: Kidneys have on participant experience? 
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3. Methods  
 
3.1 Study design 
 
This mixed methodology prospective cohort study examined the effects of the 
structured group education module Diabetes Essentials: Kidneys. The education 
session aimed to improve knowledge, sense of SE in relation to DKD management and 
encourage SM practices in relation to DKD to assist people to achieve their goals. 
 
The study took place over a six month period from March to September 2013, 
incorporating participants attending one of four standalone education modules, which 
were held monthly. Study participants were followed for a twelve week period. All 
participants in the research had access to the educational module; therefore no 
participants had clinical care withheld.  
 
The study provided the opportunity to identify the relationship between the education 
module and outcome measurements. Quantitative data in the form of self-completed 
questionnaires for the dependent variables knowledge, SM and SE relating to the 
educational module were completed immediately prior to the education module and 
repeated at six and twelve weeks post intervention. Qualitative semi-structured 
interviews were undertaken six weeks post education intervention in order to determine 
to a greater and broader degree the effects of the education module on participants. 
The interviews encouraged participants to provide an insight into their experience of 
the education module, its effects on their self-care practices and give a greater 
understanding of the potential relationship which exists between the dependent 
variables measured.  
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3.1.1 Ethical approval  
 
Ethical approval for the research project was granted with conditions by National 
Research Ethic Service (NRES) Committee North West (Preston) on the 26th February 
2013. These conditions were met and full approval granted on February 28th 2013 
(Appendix 1). The Countess of Chester Hospital NHS Foundation Trust Research and 
Innovation Department subsequently granted approval for the project (Appendix 2).  
 
3.1.2 Dependent Variable  
3.1.2.1 Quantitative data  
The Chronic Kidney Disease self- management (CKD-SM) instrument (Lin et al., 
2012a);Chronic Kidney Disease self-efficacy (CKD-SE) instrument (Lin et al., 2012b) 
and the Kidney Knowledge Survey (KiKS)) (Wright, Wallston, Elasy, Ikizler, & 
Cavanaugh, 2011) were used in this study. These questionnaires did not require 
licence agreements; however through personal communication with the authors, 
permission was requested and granted on the basis that the publications were 
acknowledged (Appendix 7 and Appendix 8). 
 
3.1.2.2 CKD-SM instrument 
 
The CKD-SM instrument (Appendix 11) is a valid and reliable measurement of SM 
behaviour for individuals with CKD (Lin et al., 2012a). The tool has been used in a 
population with CKD, mainly stage 2 and stage 3 CKD and has been shown to have 
good internal consistency and test-retest correlation, and a high sampling adequacy 
(Lin et al., 2012a).  
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This questionnaire rates on a scale of one to four, how often the participant completes 
or considers a certain self-care activity, with one meaning they never carry out the task 
and four meaning they always carry out the task. The questions investigate the level of 
SM in relation to factors influencing kidney health including diet, exercise, and smoking, 
sourcing information, questioning laboratory results and seeking support both from 
health professionals and social circle. This questionnaire was used at three points 
during the research, at baseline and six and twelve weeks post intervention.  
 
A major drawback of the CKD-SM instrument for the current research is that there is no 
English translation of the tool as it was originally developed for use amongst a 
Taiwanese population. However, a review of the literature failed to identify other 
suitable CKD specific SM tools and it is acknowledged that there is a lack of validated 
questionnaires for use in people with CKD (Mason et al., 2008). For that reason the 
tool was based on the information provided in the English publication of the article in 
order to produce an English version of the tool. This modification of translating the 
instrument to English was the only modification made to the tool.  
 
3.2.2.3 CKD-SE instrument  
 
The Chronic Kidney Disease self-efficacy (CKD-SE) instrument (Appendix 12) is used 
in order to identify the behaviours of individuals with early CKD. It has been shown to 
have a high sample adequacy and good internal consistency in a population with CKD 
Stages 1-3 (Lin et al., 2012b). The original instrument was developed in Chinese and 
translated to English by the instruments’ authors. The questionnaire rates on a scale of 
one to ten how confident the participant feels in relation to a scenario or daily living 
activity that is important in the management of CKD. A score of one means not 
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confident in that particular scenario/activity while a score of ten means extremely 
confident.  This questionnaire was used at three points during the research, at 
baseline, immediately post intervention and six and twelve weeks post intervention. 
 
Unfortunately for both the CKD-SE and CKD-SM instruments there are no published 
studies which have used the tools as part of an intervention as yet. This is perhaps as 
they are relatively new tools, therefore there is no available data on the use of the tool 
to measure change following an intervention. Generic chronic disease and diabetes 
specific SE (Lorig et al., 1996; Talbot, Nouwen, Gingras, Gosselin, & Audet, 2007) and 
SM tools are available (Toobert, Hampson & Glasgow, 2000; Wallston, Rothman, & 
Cherrington, 2007), however it was decided that CKD specific instruments would give a 
better indication of SM and SE in this population with DKD.  
 
3.1.2.4 KiKS 
 
The  KiKS tool (Appendix 13) measured CKD knowledge in patients across all stages 
of CKD with an emphasis on early CKD (Stages 1- 3). The survey has previously been 
tested in a group of adults with CKD stages 1-5 and shown to have good internal 
consistency. Higher scores have been positively and independently associated with 
younger age, greater health literacy, previous participation in a kidney education class 
and awareness of CKD diagnosis (Wright et al., 2011).  
 
The survey consists of twenty-eight multiple choice questions. For the purposes of this 
project, the questionnaire was modified to the extent that questions which addressed 
issues not included in the education module were removed. This focused participant 
responses on measuring knowledge based on that which was delivered through the 
33 
 
module being investigated. This eliminated twelve questions and reduced the survey to 
sixteen multiple choice questions. As the development of the questionnaire weighted all 
the questions the same, the removal of unsuitable questions did not impact the 
outcome of the questions used in terms of the validity of the results. 
 
3.1.2.2 Qualitative data 
Semi-structured interviews were employed in order to give a greater degree of insight 
into the participants’ experience and views of the education module. The advantage of 
this type of research is that it gives a greater level of detail and appreciation of human 
issues and offers more flexibility to identity relationships between complex matters 
(Bryman & Burgess, 1994; Marshall, 1996). Qualitative research has been described 
as a method of exploring experiences, perceptions, motivations and behaviour 
(Clissett, 2008). This is a benefit of this type of research in that themes, opinions or 
concepts not previously considered by the researchers, and which may be beyond the 
scope of the quantitative research, can be explored. This methodology allows for 
participant-led rather than researcher-led outcomes to be identified (Bryman, 2012).  
 
This qualitative research technique followed an interview guide (Appendix 14) which 
was used to lead the interview. However the semi-structured nature of the interview 
meant that participant-initiated deviations are encouraged in order to include aspects 
important to the participant that may not have been considered or investigated by the 
researcher. All interviews were audio- recorded and transcribed verbatim.  
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 3.2 Population and subjects  
3.2.1  Sample and sample size estimation  
The current study uses a novel approach to diabetes education due to its disease 
specific module format. A review of the literature did not identify a similar educational 
intervention which means no comparable data exist to compute an effect size 
difference with which to perform a power calculation to determine an appropriate 
sample size. Consideration of resources and capacity of the group education session 
was the greatest influential factor of the sample size recruited.  
In consideration of time and resources available recruitment to the research study was 
agreed for all education sessions from March to June 2013. With full capacity this 
would have resulted in 32 participants (each session has capacity for 8 people, and is 
delivered once per month). A feasibility study of group structured education in CKD (not 
specifically a diabetes population) reported 30% recruitment to the study (Byrne, 
Khunti, Stone, Farooqi, & Carr, 2011). The authors did acknowledge that structured 
education is a more established aspect of clinical care in the area of diabetes and this 
would potentially lead to a greater uptake. Indeed published data in SDE reports 
recruitment of up to 74% (Davies, M. J., et. al., 2008). Using these as guides to 
potential recruitment figures would suggest ten (30% recruitment) to 24 participants 
(74% recruitment) in the education sessions would participate in the research. 
 
Bacchetti, Deeks, & McCune, (2011) explain that in a novel study, it is “impossible” to 
predict whether an intervention will have breakthrough effect, some value or no impact 
on outcomes. A small sample size would be sufficient to detect breakthrough effects 
while in a study with no impact a large sample size would be wasteful.  A small sample 
size can be beneficial as it is more cost effective and considerate of time and resources 
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available (Bacchetti et al., 2011) and potentially assist in further research without 
creating an unnecessary burden or expense  
 
In the qualitative research, recruitment of subjects used purposive sampling which 
means those who have knowledge of the topic are involved in the research (Bryman, 
2004). Therefore those who participated in the quantitative element of the research 
were also invited to partake in the qualitative research until study saturation had been 
achieved.  
 
3.2.2 Recruitment  
Suitable participants for this research project were identified from those scheduled to 
attend the Diabetes Essentials: Kidneys education module delivered at the Countess of 
Chester Hospital NHS Foundation Trust. Two methods exist for booking a place on this 
education session. Individuals are either referred onto this module by a healthcare 
professional, generally a member of the diabetes specialist team, or individuals could 
contact a dedicated telephone number to reserve a place themselves. (A number of 
referrals were generated by individuals reserving a place themselves after they had 
received a letter highlighting their suitability for the module from their GP). Potential 
participants were contacted by letter to invite them to partake in the research (Appendix 
5) and this was subsequently followed up with a telephone call.    
 
3.3.3 Eligibility criteria  
   3.3.3.1 Inclusion criteria   
 Adults over the age of 18 years of age 
 Diagnosed diabetes mellitus (type 1 or type 2) 
 Diagnosed CKD related to diabetes  
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 Presenting with either: 
o CKD Stage 3: estimated glomerular filtration rate (eGFR) 30-60 
ml/min/1.73m2 
o Proteinuria: albumin:creatinine ratio (ACR) of 30 mg/mmol or more  
 Individuals registered to a GP within Western Cheshire Clinical Commissioning 
Group (CCG) or under the care of the Diabetes Specialist Team at the Countess of 
Chester Hospital NHS Foundation Trust 
 
  3.3.3.2 Exclusion criteria  
 Young persons under the age of eighteen  
 Pregnancy 
 Unable to provide informed consent 
 Unable to communicate proficiently through English 
 CKD Stage 4 or 5 (i.e. an eGFR less than 30 mL/min/1.73m2) 
 CKD unrelated to diabetes 
 
3.2.4 Consent  
Participants were contacted by postal invitation a minimum of seven days prior to the 
scheduled first visit and were provided with the participant information (PI) sheet 
(Appendix 6) at this contact. All participants had the opportunity to talk through the 
research project with the researcher at the initial telephone contact and again at Visit 1 at 
the trial site. Written informed consent (Appendix 3) was taken at the first clinic visit prior to 
any study procedures taking place.  
 
Written consent for those participating in the qualitative component of the research was 
taken prior to the semi-structured interviews (Appendix 4). For those who opted for this 
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contact as a telephone interview, their consent form was sent to their home address and 
returned to the researcher prior to this contact being made. 
 
3.2.5 Participant reimbursement  
Through the funding secured for this study from the Cheshire and Merseyside Allied 
Health Professional (AHP) Research Network participants were reimbursed for their travel 
and parking expenses incurred during the course of participation in the research. 
 
3.3 Procedures  
The delivery of the ‘Diabetes Essentials: Kidneys’ education module was facilitated by a 
diabetes specialist nurse (DSN) with specialist interest in DKD and by the author of this 
research project, who is a registered dietitian. The module is delivered as a standalone 
session at the Diabetes Unit of the Countess of Chester Hospital (COCH) NHS Foundation 
Trust. For a description of the education module see Appendix 19.  Other study 
procedures relating to the management and data collection of the quantitative research 
was carried out by the author.  
The qualitative research in the form of the conduct, transcription and analysis of the semi-
structured interviews was led by researchers from the Centre of Public Health, Faculty of 
Health and Social Sciences at Liverpool John Moores University. The study author was 
involved in the analysis of the interviews in order to provide a second independent 
interpretation of the key issues, concepts and themes.  
 
The study procedures were carried out over a six month period between March and 
September 2013, with each participant actively involved for a period of twelve weeks within 
this time frame. All the study activities were carried out at either the Diabetes Unit at the 
COCH or in the participants’ own home (week 12 self-completed questionnaires). 
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 Figure 1: Flowchart indicating participant flow through the study   
  
Contact 1 
Invitation to participate in research (Appendix 5) 
and Participant Information Sheet (PI sheet) 
(Appendix 6) sent to participants scheduled to 
attend ‘Diabetes Essentials: Kidneys’ 
Contact 2 
Follow-up telephone contact to discuss the 
research and time arranged for baseline data 
collection 
Visit 1: Baseline Visit 
Potential participants attend study site immediately prior to 
scheduled education session 
‐ Written consent and baseline data collection 
‐ Delivery of the education module ‘Diabetes Essentials: Kidneys’ 
‐ Post-education data collection 
Visit 2: 6 weeks post intervention 
Completion of semi-structured qualitative 
interviews 
Quantitative data collection 
Visit 3: 12 weeks post intervention 
Data collection by method preferred by the participant 
Individual at the study site/telephone/postal contact 
 
This concludes participant’s involvement in the study 
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3.4 Statistical analyses  
SPSS statistics 20 (IBM) was used for the statistical analysis of the data. A value of 0.05 
was considered statistically significant with a 95% confidence level used to interpret the 
results.  
Each of the demographics was explored using descriptive statistics including the central 
distributions and dispersion of the data, in order to describe the characteristics of the study 
population. Sample percentages were calculated for each of the demographics (gender, 
ethnicity, employment status, educational attainment) and median and inter-quartile rage 
(IQR) calculated for clinical characteristics (number of other diabetes complications, 
previous diabetes education, and medication category). 
 
3.4.1 Quantitative data 
CKD-SE and CKD-SM questionnaires generated results at three separate time points in 
the form of ordinal data. Visual inspection of this data using histograms, Q-Q plots and 
detrended Q-Q plots identified a distribution which was positively skewed.  Boxplots of 
distribution showed the majority of results were skewed towards the higher range of the 
scales used with whiskers towards the lower values. Median and IQR were used to 
present the central distribution and dispersion of the results. Friedman tests were used to 
compare changes in these outcome variables. The KiKS results were in the form of binary 
data. Percentage correct and in-correct was calculated for this data, which was generated 
at four distinct time points. Spearman rank-order correlation coefficient was used to detect 
whether association between CKD-SM, CKD-SE and KiKS existed.  
 
Multivariate logistic regression analyses to estimate relationships between SE, SE and 
knowledge, however during data analysis it was decided that identifying relationships 
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between the qualitative and quantitative results would add much more value to the 
outcomes, above that which would be generated from a regression analysis. 
 
3.4.2 Qualitative data 
To fully capture the data all interviews were transcribed verbatim. Each transcript was 
scrutinised independently by two researchers and an index of all the key issues, concepts 
and themes devised drawing on issues linked to the aims and objectives of the study 
combined with issues expressed by participants themselves.  
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4. Results 
4.1 Participant recruitment and progression 
All those registered to attend “Diabetes Essentials: Kidneys” between the study period 
(March to June 2014) were invited to participate in the research, this resulted in invitation 
to thirty-three patients across four sessions. Twenty-two individuals (66.7%) attended the 
education session and of those who attended fifteen (68.2%) were recruited to the 
research. 
Of those who agreed to participate, two (13.3%) were excluded from the research due to 
improvements in biomedical measures (specifically estimated glomerular filtration rate 
[eGFR]).  Thirteen eligible people who meet the inclusion criteria agreed to take part in the 
research, representing a 39.4% uptake of the research project by those invited. Figure X 
illustrates participant flow through the study. 
Participant attrition for the study was low, with all thirteen of those eligible participants 
continuing for the duration of the research, completing the three contacts over a three 
month period. Eleven participated in the qualitative research, as it was felt saturation had 
been reached in terms of outcomes. 
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Figure 2: Flowchart indicating participant flow through the study   
 
33 potential participants 
contacted  
15 potential participants consent 
to participate 
22 patients 
attend 
2 participants excluded due to 
eGFR >60 ml/min/1.73m2 
Visit 2 
11 participants complete qualitative research  
All 13 complete questionnaires 
Visit 1:13 participants complete  
11 patients decline 
involvement  
Visit 3 
12 complete via postal contact; 1 at 
study site 
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4.2 Baseline characteristics  
 
The study population was adults, with optimal or slightly above optimal diabetes control 
(56 mmol/mol [55 mmol/mol -64 mmol/mol]) and in CKD Stage 3 (Table 1). All participants 
were white British, 23% were female and 76% were male, the majority were retired (85%) 
with only 15% in employment; which is not unexpected given the median age (70 years 
[61.2-78.5 years]). Only one of the participants had T1DM (7.7%) while the remaining 
twelve had T2DM (92.3%). The median duration of diabetes and DKD was 15 (10-23) 
years and 7 (6-7) years respectively. Table 1 below outlines other biomedical and 
anthropometric characteristics. 
 
4.2.1 Diabetes management  
 
Diabetes management included a spectrum of medication ranging from monotherapy with 
oral hypoglycaemic agents (OHA) to triple therapy using insulin in combination with an 
OHA and a GLP-1 analogue; none of the participants were management through diet and 
lifestyle alone, 15.4% required one OHA; 7.7% required two OHAs; 46.1% percent of 
participants required insulin alone ;23.1% required insulin in combination with an OHA and 
7.7% required a tertiary regime of insulin, GLP-1 analogue and an OHA.  
 
The median number of anti-hypertensive and dyslipidaemia medication classes used was 
3 (2.5-4.0) and 1 (1-1) respectively.  
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Table 1: Biomedical and anthropometric results (≤ 3 months from baseline)  
Variable Result 
HbA1c (mmol/mol) 56 (55-64) 
eGFR (ml/min/1.73m2) 38.9 (34.1-44.6) 
Microalbuminuria (mg/mmol) * 1.95 (0.57-2.96) 
Proteinuria (mg/mmol) ** 185.00 (76.50-348.73) 
Total Cholesterol (mm/L) 3.90 (3.35-4.25) 
HDL Cholesterol (mm/L) 1.0 (0.80-1.30) 
Total:HDL ratio  3.63 (3.20-4.44) 
Triglycerides (mmol/L) 3.30 (1.55-3.55) 
Systolic Blood Pressure (mmHG) 140 (119-152) 
Diastolic Blood Pressure (mmHG) 71 (64-82) 
Height (m) 1.72 (1.66-1.81) 
Weight (kg) 94.8 (85.2-107.7) 
BMI (kg/m2) 31.9 (29.2-37.2) 
  
 
Median (interquartile range); *53.8% (N=7) of participants had microalbuminuria;   
** 46.2% (N=6) of participants had proteinuria  
 
The majority (77%) of this group with DKD also present with other complications of 
diabetes as indicated in Table 2. Retinopathy and CVD were the most commonly 
accompanying co-morbidity, both affecting 61.5% of the study group (Table 2).  
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Table 2: Complications related to diabetes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*All have DKD, none refers to those with only DKD 
 
  
Complication of Diabetes N (%) 
           Retinopathy 8 (61.5) 
           Neuropathy 3 (23.1) 
           Cardiovascular disease 8 (61.5) 
           Peripheral vascular disease 2 (15.4) 
Number of other diabetes complications  
           None* 3 (23.1) 
           One  3 (23.1) 
           Two  4 (30.8) 
           Three  2 (15.4) 
           Four  1 (7.7) 
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4.2.2 Formal education 
 
Previous formal education varied, as shown in Table 3, with the highest proportion of 
participants having the highest qualification of work related or other vocational qualification 
(30.8%) or an apprenticeship (15.4%).  
 
Table 3: Highest level of formal educational attained  
Educational Attainment Participants 
N (%) 
1-4 O Levels, CSEs, GCSEs (any grade), Entry Level, Foundation 
Diploma 
0 (0.0) 
NVQ Level 1, Foundation GNVQ, Basic Skills 0 (0.0) 
5+ O Levels (passes), CSEs (grade 1), GCSEs (grades (A*-C), School 
Certificate, 1 A level, 2-3 AS levels, VCEs, Higher Diploma 
1 (7.7) 
NVQ  Level 2, Intermediate GNVQ, City and Guilds Craft, BTEC 
First/General Diploma, RSA Diploma  
1 (7.7) 
Apprenticeship  2 (15.4) 
2+ A levels/VCEs, 4+AS levels, Higher School Certificate, 
Progression/Advanced Diploma  
0 (0.0) 
NVQ Level 3, Advanced GNVQ, City and Guilds Advanced Craft, ONC, 
OND, BTEC National, RSA Advanced Diploma  
1 (7.7) 
Degree (for example BA, BSc), Higher degree (for example MA, PhD, 
PGCE) 
1 (7.7) 
NVQ Level 4-5, HNC, HND, RSA Higher Diploma, BTEC Higher Level  0 (0.0) 
Professional qualifications (for example teaching, nursing, accountancy) 1 (7.7) 
Other vocational/work related qualifications 4 (30.8) 
Foreign qualifications 1 (7.7) 
No qualifications 1 (7.7) 
  
 
4.2.2 Previous diabetes education  
Over half of participants (53.8%) self-reported prior DSE (Table 4).  Of those received DSE 
it was either in the form of individual education from a HCP (42.9%) or a DSE group 
(42.9%). Only 14.3% reported previous attendance at Diabetes Essentials, the locally 
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commissioned DSE groups for T1DM and T2DM. Details of the time spent on education 
and time since this education was received is given in detail in Table 4.   
 
Table 4: Participants previous diabetes education (values are presented as N and 
percentages of total in parentheses) 
  
 
 Yes No No 
response
Have you received previous diabetes education? 7 (53.8) 4 (30.8) 2 (15.4) 
 
 
Type of education   
 
Of those who 
answered “Yes” 
N=7 
 
Total group 
 
N=13 
     One to one education with a health professional 3 (42.9) 3 (23.1) 
     Diabetes Essentials (Local T2DM Education) 1 (14.3) 1 (7.7) 
     Other diabetes education session (e.g. X-PERT 
programme, DESMOND) 
3 (42.9) 3 (23.1) 
     Carbohydrate counting and insulin dose 
adjustment education (e.g. DISC, DAFNE) 
0 (0.0) 0 (0.0) 
    Other education 0 (0.0) 0 (0.0) 
 
Length of DM education   
      < 15 mins 1 (14.3) 1 (7.7) 
       15-30 mins 2 (28.6) 2 (15.4) 
       30-60 mins  0 
       1-3 hours  0 
       Multiple session over a number of days/weeks 4 (57.1) 4 (30.8) 
 
Time since DM education    
      Within the past six months 1 (14.3) 1 (7.7) 
      Within the previous year 0 (0.0) 0 (0.0) 
      1-2 years ago 2 (28.6) 2 (15.4) 
      2-5 years ago 0 (0.0) 0 (0.0) 
      Greater than 5 years ago 3 (42.9) 3 (23.1) 
      No response 1 (14.3) 7 (53.8) 
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4.3 Quantitative outcome measure  
4.3.1Self-management  
Table 5 shows the change in SM between each of the three time points. Significant 
improvements in the SM behaviours listed in Box 1 were observed as a result of the 
intervention.  
Where significance was achieved, it was consistently demonstrated by week six and 
maintained through to twelve weeks post intervention. As the Likert scale only used a 4 
point scale (1-4), the significance change is more effectively demonstrated in the reduction 
in IQR rather than clearly observed in the median. This suggests individual variability 
between participant’s narrows through the intervention for certain SM actions.  
 
 
Box 1: SM behaviours showing significant or trend to improvement as a result of 
intervention  
Significant improvements were displayed in the following activities;  
 Change lifestyle to avoid worsening of kidney function (x2 = 6.320, p=0.042) 
 Actively seek information about kidney disease (x2 = 13.273, p=0.001) 
 Actively seek resources to better control CKD (x2 = 13.400, p= 0.001) 
 Asking the meaning of blood and urine test results (x2 = 7.806, p=0.020) 
 Sharing experiences with other patients (x2 = 9.235, p=0.010) 
 Following healthcare professionals suggestion to adjust dietary habits (x2 = 7.786, p=0.020) 
and to exercise (x2 = 6.258, p=0.044) 
Neared significant improvement 
Finding out the reasons for signs and symptoms of CKD (x2 = 5.429, p=0.066).  
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Table 5: Outcome of CKD-SM questionnaire from baseline to twelve weeks post intervention 
Values are median (Interquartile range) 
 
 
 
All score range from 1 (never do this activity) to 4 (always to this activity)  
α value of p< 0.05 
** denotes statistically significant result at α-level of 0.05  
 
Question Baseline Week 6 Week 12 x² 
p 
value 
Pay attention to habits that affect kidney function 3.00 (3.00-4.00) 4.00 (3.00-4.00) 3.00 (3.00-4.00) 0.636 0.727 
Adjust food portions and choices when eating out 3.00 (2.00-3.50) 3.00 (3.00-4.00) 3.00 (3.00-3.00) 2.529 0.282 
Give up habits harmful to kidneys 3.00 (3.00-4.00) 3.00 (3.00-4.00) 4.00 (3.00-4.00) 1.000 0.607 
Adjust things to look after your kidneys to fit 
different situations 3.00 (2.00-4.00) 3.00 (2.50-4.00) 3.00  (3.00-3.00) 0.200 0.905 
Choose food options to avoid harming kidneys 3.50 (3.00-4.00) 3.00 (3.00-4.00) 4.00 (3.00-4.00) 1.000 0.607 
Manage CKD to stay healthy 3.00 (2.50-4.00) 4.00 (3.00-4.00) 3.00 (3.00-4.00) 5.120 0.770 
Fit the things you need to do to look after your 
kidneys 4.00 (3.00-4.00) 4.00 (3.25-4.00) 4.00 (3.00-4.00) 2.333 0.311 
Adjust lifestyle to maintain kidneys in best condition 3.00 (2.50-4.00) 3.00 (2.75-4.00) 3.00 (3.00-4.00) 1.032 0.597 
Participate selectively or avoid certain social 
activities 3.00 (2.00-4.00) 3.00 (3.00-4.00) 3.00 (3.00-4.00) 2.690 0.261 
Change lifestyle to avoid worsening of kidney 
function ** 3.00 (3.00-4.00) 4.00 (3.00-4.00) 4.00 (3.00-4.00) 6.320 0.042 
Actively seek information about kidney disease ** 3.00 (1.00-3.00) 3.00 (3.00-4.00) 3.00 (3.00-4.00) 13.273 0.001 
Actively seek resources to better control CKD ** 2.00 (2.00-3.00) 3.00 (3.00-4.00) 3.00 (3.00-4.00) 13.400 0.001 
Use different ways to clarify questions about 
treatment plan 3.00 (2.00-4.00) 3.00 (3.00-4.00) 3.00 (3.00-4.00) 0.250 0.882 
Use different ways to solve problems 3.00 (2.00-3.50) 3.00 (3.00-3.50) 3.00 (3.00-3.50) 2.000 0.368 
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Table 5: Continued  
Values are median (Interquartile range) 
 
 
All score range from 1 (never do this activity) to 4 (always to this activity)  
α value of p< 0.05 
** denotes statistically significant result at α-level of 0.05  
  
Question Baseline Week 6 Week 12 x² 
p 
value 
Find out reasons for signs and symptoms of CKD 3.00 (2.00-3.00) 3.00 (2.50-4.00) 3.00 (3.00-3.50) 5.429 0.066 
Think about reasons for abnormal blood or urine results 3.00 (2.50-3.50) 2 .00(2.50-4.00) 3.00 (3.00-3.50) 0.889 0.641 
Find out possible reasons for high blood pressure 3.00 (2.00-3.50) 3.00 (3.00-4.00) 3.00 (3.00-4.00) 2.077 0.354 
Ask the meaning of blood and urine test results ** 3.00 (2.00-3.50) 3.00 (3.00-4.00) 4.00 (3.00-4.00) 7.806 0.020 
Seek to understand risk factors for CKD 3.00 (2.50-3.00) 4.00 (3.00-4.00) 3.00 (3.00-4.00) 8.063 0.180 
Share experiences with other patients ** 1.00 (1.00-3.00 2.00 (2.00-2.50) 3.00 (2.00-3.00) 9.235 0.010 
Share feelings of helplessness or frustration with other 
patients 1.00 (1.00-2.75) 2.00 (1.25-2.75) 2.00 (2.00-3.00) 2.882 0.237 
Ask family or friends for help when feeling helpless or 
frustrated 2.00 (1.00-3.75) 2.00 (2.00-3.75) 3.00 (2.00-3.00) 2.385 0.304 
Discuss questions or worries with family or friends 2.50(2.00-3.75) 2.50 (2.00-3.75) 3.00 (2.25-3.00) 1.391 0.499 
Tell family or friends about CKD treatment plan 2.00 (2.00-4.00) 3.00 (2.00-4.00) 3.00 (2.00-4.00) 1.188 0.552 
Follow healthcare professionals suggestion to adjust 
dietary habits 3.00 (3.00-3.00) 4.00 (3.00-4.00) 4.00 (3.00-4.00) 7.786 0.020 
Follow healthcare professionals suggestion to control 
your weight 3.00 (3.00-4.00) 3.00 (3.00-4.00) 3.00 (3.00-4.00) 0.222 0.895 
Follow healthcare professionals suggestion to exercise 2.00 (2.00-3.00) 3.00 (2.50-3.50) 3.00 (3.00-4.00) 6.258 0.044 
Follow dietitians suggestions on choosing food 3.00 (3.00-4.00) 4.00 (3.00-4.00) 3.50 (3.00-4.00) 2.333 0.311 
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4.3.2 Self-efficacy 
Reported levels of SE at baseline are on the higher side of the scale range (Table 6). 
Statistically significant changes are not apparent in the majority of SE measures however 
there are a number which do show improvements. Similar to SM results, this improvement 
appears to be most apparent between pre and post education questionnaires, with 
maintenance of this improvement through to twelve weeks post intervention. The variable 
of most significant change is “I can understand the meaning of the CKD-related blood & 
urine results” which clearly shows an increases between pre and post education (median 
[IQR] 3.50 (1.25-6.50) pre-education versus 8.50 [8.00-10.00] post-education). Changes in 
the other variables show improvements in the median value, in combination with clear 
narrowing of the IQR (Table 6).  
 
 
52 
 
Table 6: Outcome of CKD-SE questionnaire from baseline to twelve weeks post intervention 
Values are median (Interquartile range) 
 
All score range from 0 (not confident) to 10 (extremely confident) 
α value of p< 0.05;  
** denotes statistically significant result at α –level of 0.05  
  
Question Baseline Post education Week 6 Week 12 x² p value 
Comfortable telling others 
that I suffer from CKD 6.50 (2.74-10.00) 8.00 (8.00-10.00) 8.00 (4.50-9.75) 9.00 (5.25-10.00) 6.523 0.089 
Seek information to 
explains CKD related signs 
& symptoms 7.50 (2.75-9.75) 9.50 (8.00-10.00) 9.00 (8.00-10.00) 9.00 (8.00-10.00) 10.120 0.180 
Understand the meaning of 
the CKD-related blood & 
urine results ** 3.50 (1.25-6.50) 8.50 (8.00-10.00) 9.00 (7.25-9.00) 8.50 (8.00-10.00) 16.515 0.001 
Accept the fact that I suffer 
from CKD 8.25 (8.00-10.00) 9.00 (8.00-10.00) 10.00 (8.00-10.00) 10.00 (8.25-10.00) 2.544 0.467 
Understand the risk factors 
associated with CKD ** 8.50 (6.25-9.75) 9.50 (8.25-10.00) 9.00 (8.00-10.00) 10.00 (9.00-10.00) 11.300 0.01 
Able to discuss my worries 
with my family/friends 9.00 (5.25-10.00) 8.50 (5.00-10.00) 9.00 (7.25-10.00) 9.00 (5.75-10.00) 1.838 0.607 
Seek help if I am stressed 
out so as not to affect my 
disease 6.00 (5.00-8.75) 8.50 (5.25-10.00) 7.50 (6.00-10.00) 8.00 (7.25-9.00) 2.971 0.396 
Seek out precautions to 
prevent my CKD from 
worsening 7.50 (6.25-9.75) 8.50 (8.00-10.00) 8.50 (8.00-9.00) 9.00 (8.25-10.00) 7.700 0.530 
Willing to share CKD SM 
experiences with other 
patients 8.00 (7.00-10.00) 8.00 (7.00-10..00) 9.00 (5.50-10.00) 9.00 (5.50-10.00) 1.854 0.603 
 
53 
 
Table 6: Continued 
 
 
All score range from 0 (not confident) to 10 (extremely confident) 
α value of p< 0.05;  
** denotes statistically significant result at α –level of 0.05  
  
Question Baseline Post education Week 6 Week 12 x² p value 
Adjust management of my 
CKD to fit different 
situations 8.00 (6.50-9.00) 8.00 (8.00-10.00) 8.00 (8.00-10.00) 8.00 (8.00-10-00) 5.355 0.148 
Comfortable asking HPC 
about my current medical 
conditions 10.00 (7.50-10.00) 9.00 (8.00-10.00) 9.00 (8.00-9.50) 9.00 (9.00-10.00) 5.692 0.128 
Face the challenges of 
living with CKD  9.00 (7.00-10.00) 9.00 (8.50-10.00) 9.00 (8.00-10.00) 10.00 (9.00-10.00) 6.853 0.077 
Actively seek out resources 
to better control of my CKD 
** 8.00 (6.50-9.50) 9.00 (8.00-10.00) 10.00 (8.50-10.00) 10.00 (8.00-10.00) 13.145 0.004 
Tell my family/friends about 
my CKD treatment plans to 
gain support 9.00 (6.50-10.00) 9.00 (5.50-10.00) 8.00 (7.50-10.00) 9.00 (6.50-10.00) 0.484 0.922 
Able to control my diet, 
even if attending a 
celebration 8.00 (5.50-8.50) 9.00 (8.00-10.00) 8.00 (7.50-9.50) 8.00 (7.50-9.00) 2.758 0.431 
Able to manage my CKD as I 
am maintaining my health 8.00 (6.50-8.00) 9.00 (8.00-10.00) 9.00 (7.50-10.00) 9.00 (7.50-9.50) 7.410 0.060 
Take the initiative to tell 
doctors that I am suffering 
from CKD 8.00 (8.00-10.00) 10.00 (8.00-10.00) 9.00 (8.50-10.00) 10.00 (9.00-10.00) 5.960 0.114 
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Table 6: Continued 
 
All score range from 0 (not confident) to 10 (extremely confident) 
α value of p< 0.05;  
** denotes statistically significant result at α –level of 0.05  
Question Baseline Post education Week 6 Week 12 x² p value 
Ask my doctor for advice when 
questions about medications 
occur to me 9.00 (8.00-10.00) 10.00 (8.50-10.00) 9.00 (8.50-10.00) 9.00 (9.00-10.00) 2.065 0.559 
Choose  appropriate 
type/amount of food when 
participating in social activities 8.00 (6.50-9.00) 8.00 (8.00-10.00) 8.00 (8.00-9.00) 8.00 (8.00-8.50) 3.063 0.382 
Look for information related to 
CKD through various channels  8.00 (6.50-9.50) 9.00 (7.50-10.00) 10.00 (8.50-10.00) 10.00 (8.50-10.00) 6.065 0.108 
Contact HCP for advice when 
questions occur even without a 
scheduled appointment 8.00 (5.50-9.00) 9.00 (8.00-10.00) 9.00 (8.00-10.00) 8.00 (7.50-10.00) 5.864 0.118 
Adhere to the diet restrictions 
recommended by the healthcare 
professionals 7.00 (6.00-9.00) 8.00 (8.00-8.375) 8.50 (7.00-9.00) 8.50 (7.00-9.00) 2.882 0.410 
Adjust dietary habits on 
recommendations of the 
dietitian/HCP 7.00 (6.00-9.00) 8.00 (8.00-8.75) 9.00 (7.00-9.50) 8.00 (7.50-9.00) 1.402 0.705 
Selectively participate in social 
activities to control of my CKD 8.00 (6.00-8.50) 8.00 (7.00-8.00) 8.00 (7.00-9.00) 8.00 (7.00-9.00) 0.309 0.958 
Seek help from family/friends 
when feeling 
depressed/frustrated with CKD 8.00 (4.00-9.50) 9.00 (6.50-10.00) 9.00 (7.00-10.00) 8.00 (5.50-9.00) 3.607 0.307 
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4.3.3 Knowledge 
Results of the KiKS show that there is a 93.8% improvement in knowledge outcomes as a 
result of the education session (Table 7). No reduction in knowledge was displayed and 
the remaining 6.2% of questions (N=1) remained the same.  
The number of people responding correctly to the questions at Visit 2 (6 weeks post 
intervention) declined from Visit 1 post education (Table 7). Considering percentage 
correct answers only would suggest that knowledge declined at Visit 2, however this is an 
increase in non-responses to 68.8% of questions and an increase in incorrect responses in 
56.3% of the questions. 
 
Percentage of correct answers at visit 3 (12 weeks post intervention) increased from visit 2 
(6 weeks post intervention) in 87.5% of questions, which was in combination with a 
reduction in incorrect in 37.5% of the questions and a reduction in no responses in 68.8% 
of the questions. In 75.0% of questions at visit 3, percentage questions correct was higher 
than baseline. 62.5% of questions at visit 3 are higher than at baseline but not as high as 
they had been immediate post-intervention. 
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Table 7: Total scores from the KiKs at four time points showing correct, incorrect and no responses 
Presented as total percentages of responses in each category 
 
Correct Incorrect No response 
  Baseline Post Visit 2 Visit 3 Baseline Post Visit 2 Visit 3 Baseline Post Visit 2 Visit 3 
On average, what should 
blood pressure should be? 61.5 84.6 46.2 76.9 38.5 15.4 15.4 23.1 0.0 0.0 38.5 0.0 
Medication can help kidney 
health 76.9 100.0 53.8 92.3 15.4 0.0 7.7 7.7 7.7 0.0 38.5 0.0 
Too much protein in urine is 
not good  53.8 53.8 23.1 38.5 38.5 46.2 38.5 61.5 7.7 0.0 38.5 0.0 
What dose GFR mean? 53.8 76.9 53.8 84.6 23.1 23.1 7.7 15.4 23.1 0.0 38.5 0.0 
There are stages of CKD 69.2 92.3 61.5 84.6 15.4 7.7 38.5 7.7 15.4 0.0 0.0 7.7 
CKD increases heart attack 
risk 69.2 92.3 46.2 84.6 15.4 7.7 15.4 7.7 15.4 0.0 38.5 7.7 
CKD increases risk of death 69.2 84.6 53.8 84.6 23.1 15.4 7.4 7.7 7.7 0.0 38.5 7.7 
Kidneys make urine 69.2 76.9 46.2 84.6 30.8 15.4 15.4 7.7 0.0 7.7 38.5 7.7 
Kidneys clean blood 53.8 100.0 61.5 84.6 15.4 0.0 38.5 7.7 30.8 0.0 0.0 7.7 
Kidneys help bone health 15.4 100.0 46.2 61.5 53.8 0.0 15.4 23.1 30.8 0.0 38.5 15.4 
Kidneys help prevent hair 
lose 84.6 100.0 46.2 61.5 0.0 0.0 7.7 15.4 15.4 0.0 38.5 23.1 
Kidneys help red blood cell 
count 61.5 84.6 61.5 76.9 7.7 15.4 38.5 7.7 30.8 0.0 0.0 15.4 
Kidneys help keep BP 
normal  53.8 75.0 30.8 84.6 30.8 52.0 30.8 0.0 15.4 0.0 38.5 15.4 
Kidneys help blood sugars  53.8 69.2 15.4 7.7 38.5 30.8 46.2 69.2 7.7 0.0 38.5 23.1 
Kidneys help keep 
potassium levels normal  76.9 91.8 61.5 76.9 7.7 8.3 38.5 7.7 15.4 0.0 0.0 15.4 
Kidneys help keep 
phosphorus levels normal  38.5 53.8 87.5 53.8 15.4 30.8 12.5 23.1 46.2 15.4 0.0 23.1 
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4.3.4 Relationship in quantitative outcome measures 
Key self-efficacy and SM questions were correlated to identify whether relationships 
between the two factors exist. These are presented in Table 8 to Table 12 below, which 
categorised the similar questions into themes.  
These results show that for the majority of variables, a significant relationship between the 
two was not demonstrated. In the ‘food related’ questions (Table 8), there was a 
correlation between the SE variable “able to adhere to diet restrictions recommended by 
HCP” and the SM variable “follow HCP suggestion to adjust dietary habits” (rs = 0.590, 
p=0.044). There was a stronger correlation between the SE variable “able to adjust my 
dietary habits in accordance with the recommendations of the dietitians or HCP” and 
“follow dietitians suggestions on choosing food” (rs = 0.875, p<0.001).  
 
In the ability to make adjustments themed questions (Table 9), one correlation exist, which 
was between “able to manage my CKD as I am maintaining my health” and “manage CKD 
to stay healthy” (rs = 0.602, p=0.030).  
 
In terms of risk factor results, no significant correlations were found (Table 10). 
 
Seeking information and support (Table 11) showed significant positive correlations 
between “actively seek resources to better control CKD” and “I can actively seek out 
resources to better control of my CKD” (rs = 0.612, p=0.026) and also between “actively 
seek information about kidney disease” and “I am comfortable asking HCP about my 
current medical conditions” (rs = 0.746, p=0.003). 
 
Strong positive correlations were found in the area of sharing experiences (Table 12). This 
showed that participants who had high levels of SE in relation to “willing to share CKD self-
management experiences with other patients feelings” also rated high levels of “sharing 
helplessness or frustration with other patients”(Table 12) (rs = 0.724, p=0.005). SM 
activities of asking friends or family for help when feeling helpless or frustrated and 
discussion questions or worries with family of friends also correlated highly with their SE 
counterparts (rs = 0.813, p=0.001 and (rs = 0.619, p=0.024 respectively).
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Table 8: Correlations between SM and SE variables related to food 
 
 
rs  : Correlation co-efficient 
** denotes statistically significant result at α –level of 0.05 
  
Self-Management  Self-Efficacy rs p-value 
 
Adjust food portions and choices when 
eating out 
 
 
I would be able to choose the type/amount of food 
appropriate to my disease when participating in social 
activities 
0.202 0.507 
Choose food options to avoid harming 
kidneys 
I  would be able to adjust my dietary habits in 
accordance with the recommendations of the dietitians 
or HCP  
 
0.467 0.108 
 
 
Follow healthcare professionals 
suggestion to adjust your dietary 
habits ** 
 
 
I would be able to adjust my dietary habits in 
accordance with the recommendations of the dietitians 
or HCP  
 
 
Able to adhere to diet restrictions recommended by 
HCP ** 
0.467 
 
 
 
0.590 
0.108 
 
 
 
0.044 
 
Follow dietitians suggestions on 
choosing food ** 
 
 
I would be able to adjust my dietary habits in 
accordance with the recommendations of the 
dietitians or HCP ** 
0.875 0.000 
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Table 9: Correlations between SM and SE variables related to making adjustments 
 
Self-management variable Self-efficacy variable rs p-value 
Give up habits harmful to kidneys 
 
 
I would actively seek out precautions to prevent my CKD from 
worsening  
 
0.496 0.850 
 
Adjust things to look after your 
kidneys to fit different situations 
 
 
Would selectively participate in social activities (e.g. attending 
dinners or gatherings) in order to control of my CKD 
0.391 0.186 
 
Manage CKD to stay healthy 
 
 
I would be able to manage my CKD as I am maintaining my 
health 
0.602 0.030 
 
Fit the things you need to do to look 
after your kidneys 
 
 
I can face the challenges of living with CKD 
0.108 0.726 
 
Adjust lifestyle to maintain kidneys 
in best condition 
 
 
I would be able to adjust management of my CKD to fit 
different situations 
0.460 0.114 
 
Participate selectively or avoid 
certain social activities 
 
 
Would selectively participate in social activities (e.g. attending 
dinners or gatherings) in order to control of my CKD 
0.246 0.417 
    
 
rs  : Correlation co-efficient 
** denotes statistically significant result at α –level of 0.05 
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Table 10: Correlations between SM and SE variables related to risk factor results 
 
 
rs  : Correlation co-efficient 
α –level of 0.05 
 
 
 
  
Self-Management  Self-Efficacy rs p-value 
Think about reasons for abnormal blood or urine 
results 
I would actively seek out precautions to prevent my CKD 
from worsening  
0.673 0.120 
Find out possible reasons for high blood pressure
I can actively seek information to explains CKD related 
signs & symptoms  
-0.064 0.837 
Ask the meaning of blood and urine test results 
I am comfortable asking HPC about my current medical 
conditions 
I can understand the meaning of the CKD-related blood & 
urine results 
0.429 
 
 
 
0.210 
0.143 
 
 
 
0.491 
    
61 
 
Table 11: Correlations between SM and SE variables related to seeking information & support 
 
 
rs  : Correlation co-efficient 
** denotes statistically significant result at α –level of 0.05 
 
 
Self-Management  Self-Efficacy rs p-value 
Actively seek information about kidney 
disease 
I am comfortable asking HCP about my current medical 
conditions  
0.746 0.003 
Actively seek information about kidney 
disease  
 
 
Would take the initiative to contact HCP for advise whenever any 
questions about my disease or treatment occur to me, even 
without a scheduled appointment 
 
0.457 0.117 
Actively seek resources to better 
control CKD I can actively seek out resources to better control of my CKD 
0.612 0.026 
Use different ways to clarify questions 
about treatment plan 
I am comfortable asking HPC about my current medical conditions 0.532 0.061 
Use different ways to solve problems  
 
 
 
 
 
Use different ways to solve problems 
I can actively seek out resources to better control of my CKD 
 
I would take the initiative to contact the healthcare professionals 
looking after me for advice whenever any questions about my 
disease or treatment occur to me, even without a scheduled 
appointment  
 
-0.29 
 
 
 
0.272 
0.925 
 
 
 
0.369 
Find out reasons for signs and symptoms 
of CKD 
I can actively seek information to explains CKD related signs & 
symptoms 
-0.60 .846 
Use different ways to clarify questions 
about treatment plan 
I am comfortable asking HPC about my current medical conditions 0.532 0.061 
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Table 12: Correlations between SM and SE variables related to sharing experience 
 
 
 
 
 
 
 
 
 
 
rs  : Correlation co-efficient 
** denotes statistically significant result at α –level of 0.05 
 
 
 
 
 
 
 
 
Self-Management  Self-Efficacy rs p-value 
Share experiences with other patients 
I am willing to share CKD SM experiences with other 
patients 
0.508 0.706 
Share feelings of helplessness or frustration 
with other patients 
I am willing to share CKD SM experiences with 
other patients 
0.724 0.005 
Ask family or friends for help when feeling 
helpless or frustrated 
Can actively seek help from my family or friends 
whenever I am feeling depressed or frustrated 
with my CKD 
0.813 0.001 
Discuss questions or worries with family or 
friends 
I would be able to discuss my worries with my 
family/friends for solutions 
0.619 0.024 
Tell family or friends about CKD treatment plan 
I can tell my family/friends about my CKD treatment 
plans to gain support 
0.0504 0.079 
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4.3.4.1 Correlation between total knowledge score and SM  
 
There was a moderate positive correlation between total knowledge and two of the SM 
statements at week 12 (Table 13). Paying attention to factors which affect kidney function 
(rs = 0.579, p=0.039) and adjusting food portions and choices when eating out (rs = 0.558, 
p=0.047) were both correlated to knowledge scores at week 12.  
Table 13 shows a lack of correlation between total knowledge score and other SM 
variables when each of the SM variables were correlated with total knowledge score at 
week 12.  
 
 
4.3.4.2 Correlation between total knowledge score and SE 
 
No correlation was found between any of the SE and total knowledge score at week 12 
(Table 14).   
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Table 13: Correlations between total knowledge score (percentage questions 
correct) and self-management activities at Week 12  
 
rs  : Correlation co-efficient 
** denotes statistically significant result at α-level of 0.05 
  
   
Self-Management Activity  rs p-value 
Pay attention to habits that affect kidney function ** 0.576 0.039 
Adjust food portions and choices when eating out ** 0.558 0.047 
Give up habits harmful to kidneys 0.332 0.268 
Adjust things to look after your kidneys to fit different situations -0.257 0.396 
Choose food options to avoid harming kidneys 0.064 0.836 
Manage CKD to stay healthy 0.289 0.339 
Fit the things you need to do to look after your kidneys ** 0.612 0.026 
Adjust lifestyle to maintain kidneys in best condition -0.137 0.656 
Participate selectively or avoid certain social activities 0.024 0.937 
Change lifestyle to avoid worsening of kidney function -0.083 0.787 
Actively seek information about kidney disease 0.182 0.552 
Actively seek resources to better control CKD -0.171 0.576 
Use different ways to clarify questions about treatment plan -0.250 0.411 
Use different ways to solve problems 0.052 0.866 
Find out reasons for signs and symptoms of CKD -0.344 0.250 
Think about reasons for abnormal blood or urine results 0.135 0.660 
Find out possible reasons for high blood pressure 0.212 0.486 
Ask the meaning of blood and urine test results -0.478 0.099 
Seek to understand risk factors for CKD -0.540 0.057 
Share experiences with other patients -0.250 0.411 
Share feelings of helplessness or frustration with other patients 0.255 0.400 
Ask family or friends for help when feeling helpless or frustrated -0.072 0.814 
Discuss questions or worries with family or friends -0.054 0.861 
Tell family or friends about CKD treatment plan -0.111 0.719 
Follow healthcare professionals suggestion to adjust dietary 
habits 
0.463 0.137 
Follow healthcare professionals suggestion to control your 
weight 
0.314 0.296 
Follow healthcare professionals suggestion to exercise 0.212 0.486 
Follow dietitians suggestions on choosing food 0.127 0.680 
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Table 14: Correlations between total knowledge score (percentage questions 
correct) and self-efficacy at Week 12  
 
rs  : Correlation co-efficient 
α-level of 0.05 
   
Self-Efficacy  rs p-value 
Comfortable telling others that I suffer from CKD -0.238 0.433 
Seek information to explains CKD related signs & symptoms -0.142 0.643 
Understand the meaning of the CKD-related blood & urine 
results 
0.163 0.595 
Accept the fact that I suffer from CKD 0.017 0.956 
Understand the risk factors associated with CKD -0.190 0.952 
Able to discuss my worries with my family/friends -0.240 0.429 
Seek help if I am stressed out so as not to affect my disease -0.148 0.628 
Seek out precautions to prevent my CKD from worsening -0.191 0.532 
Willing to share CKD SM experiences with other patients 0.372 0.211 
Adjust management of my CKD to fit different situations 0.086 0.781 
Comfortable asking HPC about my current medical conditions -0.136 0.658 
Face the challenges of living with CKD  -0.407 0.167 
Actively seek out resources to better control of my CKD -0.168 0.584 
Tell my family/friends about my CKD treatment plans to gain 
support 
0.025 0.935 
Able to control my diet, even if attending a celebration 0.075 0.808 
Able to manage my CKD as I am maintaining my health 0.419 0.154 
Take the initiative to tell doctors that I am suffering from CKD -0.407 0.167 
Ask my doctor for advice when questions about medications 
occur to me 
-0.267 0.377 
Choose  appropriate type/amount of food when participating in 
social activities 
-0.056 0.855 
Look for information related to CKD through various channels  0.049 0.873 
Contact HCP for advice when questions occur even without a 
scheduled appointment 
0.148 0.630 
Adhere to the diet restrictions recommended by the healthcare 
professionals 
0.489 0.107 
Adjust dietary habits on recommendations of the dietitian/HCP 0.366 0.218 
Selectively participate in social activities to control of my CKD 0.352 0.239 
Seek help from family/friends when feeling 
depressed/frustrated with CKD 
-0.042 0.891 
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 4.4 Qualitative  
A total of eleven semi-structured qualitative interviews (QIs) were undertaken; ten were in 
the form of face-to-face interviews, nine as individual interviews and one was a paired 
interview with a husband and wife (the husband had attended the diabetes education 
session). One of the QIs was conducted as a telephone contact as the participant was 
unable to attend the study venue due to family commitments. Interviews lasted between 20 
minutes and one hour, and consent was obtained from the participant for the QI to be 
audio recorded.  
 
Overall the participant’s responses towards the sessions were positive. A number of 
themes emerged from the data, which included reinforcement, raising awareness, 
behaviour changes, coping, negative impacts, and suggested changes. Themes and sub-
themes are presented below (Table 15), with quotes to illustrate key points. 
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Table 15: Themes and direct participant quotes from qualitative interviews 
Theme Comment Direct participant quote 
Session 
Delivery and 
Content 
The delivery and content of the 
session was viewed in a positive light 
by all participants, with the majority of 
participants reporting that the 
information was provided at the right 
level, and that there was enough 
opportunity to ask questions and gain 
clarity if required.  
“It was well presented, all the slides that were there were very 
instructive and the way it was put over to us was in a way that 
anybody could understand”  
 
“It wasn’t too technical. And the slides were explaining what your 
kidneys do and things like that, there was not a lot of science in 
there it was all very basic, you know this is how it cleans your 
blood and this is what happens when things go wrong”  
 
“I think [the Dietician] gave a really comprehensive session, she 
was really good. Very very good in fact. And she made it so clear 
for them, I thought she give amazing, she was a good dietician, 
let me say that. If I was starting out it was really helpful let’s put it 
that way”  
 
The group format of the DSE was 
regarded as positive by most 
participants. Some participants felt 
that certain group members were 
asking a lot of questions or taking up 
the time of the facilitator, but on the 
whole the group setting was positive.  
 
“You’re all there doing it together cos at times you can think am I 
the only person, and it makes you realise that there’s other 
people with the same problems that you’ve got, so yeah that was 
good that”  
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Table 15 (Continued) 
 
Session 
Delivery and 
Content 
(continued) 
Participants also suggested that the 
manner in which the course content 
was delivered had helped their 
understanding. 
 
“It was well presented, all the slides that were there were very 
instructive and the way it was put over to us was in a way that 
anybody could understand” 
 
“[the course facilitator] was so informative and you know there 
was several people there that didn’t know certain things and I 
thought you’re giving easy how can I say, easy for them to 
understand, she did make it very clear to us, it was very good 
actually” 
 
One participant explained how this 
session reminded him there was 
support there if ever he needed it. 
 
 
“Well knowledge of, you’re not just, blaming yourself for 
everything, there’s always somebody at the end of a telephone to 
help, so if I, you know if different things happen, you can ring 
somebody even if it’s here, if you can’t get them on they, you 
know straight away, leave a message they’ll ring you back.” 
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Table 15 (Continued) 
 
Reinforcement 
 
All participants acknowledged having 
prior understanding of DKD and 
shared details of their lifestyle and 
health-related behaviours. Many 
participants described the education 
as reinforcing the information that 
they had previously received from 
HCPs in previous appointments. They 
felt reassured that they were following 
a healthy lifestyle. Some of the 
participants went on to describe how 
the sessions had helped them to feel 
empowered to learn that they had 
been leading the healthy lifestyle that 
was advocated within the session.  
“Because we used to go regularly to the clinic, I think everything 
we do now is a matter of course, because you do it that 
much….you feel good because you knew the things you were 
doing were okay” 
 
“I think really the messages I took were reinforced from what I’ve 
had from the dietitians and diabetic team previously, is to be 
aware when you’re going to have food and to be aware of what 
the contents of that food have in so much of the salt, the different 
types of fats, the sugars, the carbohydrates that will affect the 
diabetes and also the kidneys”  
 
“It was good to see the explanation again about what your 
kidneys do and where things can go wrong and the basics you 
know of what you’ve got to do…. I was quite reassured you know 
that apart from slipping off the wagon every now and then I was 
sort of doing the right things really” 
 
“I know I’ve got kidney problems and I know I’ve got diabetes but 
it helped to link to two in my mind, to reinforce, you know 
particularly things about salt, what you eat you know and how that 
can affect your kidneys”  
 
“Although there were things reinforced by the education session it 
was reinforcement instead of new knowledge”  
 
“In many ways what the sessions have taught me is to reinforce 
what I’ve already been thinking”  
 
“She made me feel okay because I was following the right pattern 
as far as I could understand on the charts and the information she 
was giving us on it”  
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Table 15 (Continued) 
 
Awareness 
 
Increased awareness of the impact of 
the condition on lifestyle was another 
theme identified. Many described how 
the education session had improved 
their understanding of their condition, 
and the impact that this had on their 
lifestyle. Participants also described 
what they felt they learn during the 
session. 
 
“… look out for infections that could alter my lifestyle, to look out 
for any pain over me kidneys, and just basic things really that you 
don’t associate with what goes on. Just made you aware more of 
it.”  
 
“I learnt a lot from the diet side about it like cos I knew about how 
many calories you’re meant to have, how much fat you’re meant 
to have but I learnt a lot more about the sugars and the carbs…a 
lot of it, I already knew before but there was just little bits taken 
away, like basically how the kidneys worked as well.”  
 
“I’ve had it years anyway so I already know to watch what I eat 
but it was the actual numbers, learning about the blood pressure 
that I found useful”  
 
“Since coming on this course, it’s not so much going over on food 
and eating normally but I’m more aware now to look at everything 
we’re going to eat” 
 
“My diabetes control is certainly a lot better now than it was 
because I understand more” 
 
“It made me realise when you look at some tins they are very 
misleading, and I learnt that in the class we had that day, and I 
started to take more notice of when we go shopping and have a 
meal; I will now look at the salt content and the other contents 
and I know that a lot better now” 
 
“Learning more about the carbs and the food you eat and to 
control your diabetes, and this one with the kidneys which I didn’t 
know anything about; well I thought I did but I didn’t when I came 
to answer the questions I didn’t know the answers” 
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Table 15 (Continued) 
 
Behaviour 
Change 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When asked to describe any changes 
that they had made to their lifestyle, 
since attending the course, and many 
participants were able to detail 
changes that they had made.  
 
“I try and watch fatty foods, and if I’m cooking anything I watch 
what I cook.” 
 
“I stopped using salt in my cooking anywhere and I thought I’m 
cooking without salt so if anyone wants to eat my food the salt is 
on the table and they can put it on there so that’s what I do now, 
and I just use herbs” 
 
“[The course] has encouraged me to watch what I eat, how I eat 
it… Instead of been up here with the portions I’ve cut em virtually 
in half from what I used to do” 
 
“I used to enjoy on a Sunday a sausage or something, I now 
don’t, and I make sure if we have the bacon that it’s always grilled 
and grilled on wire so the fat drips off them, and the gravy as I say 
that’s been cut out completely.” 
 
“At one stage I was having a ham and tomato bun and a banana 
each lunch time without fail. I learnt that bananas are high in 
potassium, and my potassium is high, and tomatoes are high in 
potassium, so, cut that down.” 
One participant described the benefit 
of appropriate diabetes management 
in aiding their CKD and this was seen 
as a positive learning outcome as it 
aiding anxiety levels.  
“Well I think the key message is that although I have a kidney 
dysfunction that I needn’t get into worrying about that, the key 
message is that I can look after my diabetes, and I can look after 
my kidney dysfunction” (Participant 3) 
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Table 15 (Continued) 
 
Behaviour 
Change 
(continued) 
 
Others described the impact that the 
behaviour change had had on their 
lives, and explained the effect the 
implementation of the changes had 
for them. 
“It’s the flexibility of being able to go out, and you say right I can 
do this do that and obviously keep my eye on this that and the 
other, and it’s helpful when you, otherwise your life is circled 
around your house and diet, and if you know exactly what you’re 
doing you know it’s helpful, you at least have some kind of life”  
 
 “I feel a lot better and it’s not just me saying that. People have 
stopped me and said I look a lot better, I had someone this 
morning say to me you look at lot better. So I’m very pleased”  
Anticipated 
changes  
 
Many detailed further changes that 
they would benefit from. Motivation 
and willingness to change were sub-
themes related to the issue of 
behaviour change, and issues of 
control and personal responsibility 
were raised by a lot of the 
participants, when discussing the 
changes that they knew that the 
needed to make.  
“I’d like a lot of help with trying to get meself sorted…Try and be 
as active as possible but I know I never might not be, but try and 
do things” 
 
“It’s putting it into practice. The awareness is there now, its 
converting that awareness into actual reality.” 
 
“That information was good, it was clear, it highlighted risks, but 
it’s making that next step of from the information into reality” 
 
“Well much of it I already knew, and as a diabetic, to follow some 
of the procedures I shall find rather difficult. Personally the way I 
look at it myself, I keep off refined sugars as much as possible, 
and regards anything else, I virtually ignore it.”  
 
“Well me and me wife have started dieting, well we’ve been 
dieting for months and its bloomin hard but we’d sort of already 
started that. I think exercise is the next tick box for me….I used to 
walk me neighbour’s dog but that’s stopped now and I used to be 
a keen cyclist….it’s just getting back into the routine” 
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Table 15 (Continued) 
 
Anticipated 
changes  
 
One participant described how the 
responsibility to change lay with him; 
he acknowledged the support HCPs 
can provide and resources, however 
his statement makes the SM nature 
of the condition apparent.  
“You realise if you’re not going to do anything about it it’s a waste 
of the doctors time, money, efforts, everybody right the way 
through, if you’re going to sit there and vegetate or you get the 
chance of a new lease of life, if you don’t take it you’re an idiot.”  
Barriers to 
change 
 
Participants recognise elements of 
their management that they wish to 
change or improve on, however 
identify difficulties in implementing 
and making behavioural changes. 
Some challenges were related to 
issues of motivation and overcoming 
habits, other participants spoke of 
how they felt the challenges were 
related to their health conditions. 
“I’ve been able to take charge. Yes that’s rights. Sometimes I 
wish I hadn’t got to, cos I look at the bars of chocolate and I look 
at the cakes and I think oh dear, sometimes I want to slip up”  
 
“I’ll lose weight and then I’ll put it back on and put it back on some 
more, so in terms of is it answering, it’s not unlocking my 
problem” 
 
“The only thing that hinders me is the evening, because I’m so 
tired and I sit there and think I want to eat. But now I don’t tend to 
eat except I’ll have a bag of crisps and my Horlicks. Every night 
have me bag of crisps and I have me Horlicks” 
 
“…taking more exercise, I’ve thought about it, but that’s as far as 
it’s got…. I’m aware of it. I don’t really plan because again, there 
are other things: if I start walking a lot, or speed up my walking 
then I finish up with problems with my breathing and my 
circulation; because I’ve got poor circulation, it doesn’t get round, 
and I finish up with pain in my legs and my hips. You know.”  
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Table 15 (Continued) 
 
Support 
 
 
The role of family and friends was a 
consideration for the majority of 
participants; for many this was a 
positive influence in aiding them to 
make and maintain lifestyle changes 
and help motivation levels.  
 
“With the help of my wife, I know how to look after my diabetes.” 
(Participant 3) 
 
 “I’ve got a lot of friends and my sister lives next door so I’ve got 
her as well. My friends are all members of arthritis care and they 
help a lot. One of them has recently been diagnosed as diabetic 
herself, and she’s doing diet only, so we often have a chat.” 
 
“[Support from my wife is] helpful, yeah, yeah it is….we have a bit 
of a competition every week when we get weighed you know and 
things like that.” 
 
During the paired interview, a spouse 
identified reasons for her husband’s 
weight gain and discussed how she 
needed to support her husband to 
lose weight. 
 
 
“I think I may need to sort him out for losing a little bit of weight 
because he has, it could be with it being the winter you know, and 
you’re eating different kinds of foods, so he needs to lose a little 
bit of weight at the moment, and he’s inactive as well” (wife of 
diabetic husband) 
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Table 15 (Continued) 
 
Support 
(Continued) 
In contrast to the supportive role of 
family and friends, others described 
how they lacked the support and 
encouragement they needed, 
particularly from family members, and 
the negative connotations they felt 
this had on their ability to make 
necessary behavioural changes. 
 
“Just the encouragement to do it without somebody saying well 
you can do it if you try, you know somebody to say well done, 
you’ve done that. Instead of somebody saying well you don’t do 
much, you don’t do that. You can only try.” 
 
“I think it would help if my wife would buy into the process. I work 
away from home Monday to Thursdays but if she could be part of 
the whole piece then it would make life a lot easier in that sense” 
 
“I: where would that support come from? Are you thinking 
clinicians or family members? 
P: no, family members, cos family members are very…put you 
down some times.”  
 
“I’m not actively thinking about it [making behaviour change]. If 
my wife was more actively involved, and that sounds like a cop 
out really, but there would be, I would feel that would be a real 
step forward.” 
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Table 15 (Continued) 
 
Coping  
 
Participants described their day-to-
day experiences of living with DKD 
and detailed the challenges they 
often faced in learning to live with 
their condition. Eating out and 
shopping were often mentioned 
during interviews, where participants 
spoke about no longer eating out or 
the extra steps they had to ensure 
when eating out to ensure that their 
dietary requirements were met, and 
the extra time taken checking food 
labels when shopping. 
 
 
“We don’t eat out as much now…it’s something we don’t do 
really, which is a shame, we do occasionally but it’s a shame, I 
steer clear of that a bit” (Participant 3)  
 
“For me to do a weekly shop it takes around two hours…. going 
round the store, checking the labels, checking what I’m buying…. 
and making sure what I’ve got and sort of working out well I can’t 
buy that but I can buy that make, it depends on the make. 
Normally I have a hefty bill because I have to buy branded stuff” 
(Participant 8) 
 
“When you’re shopping you select food from the shelf, you look at 
the labels and stuff, I think you’re a bit more focused on that” 
(Participant 3) 
 
77 
 
Table 15 (Continued) 
 
Coping  
 
Many participants described the 
challenges that they faced in having 
to deal with multiple conditions, and 
the conflicting advice and information 
that they have to process and act 
upon. 
 
“So I had two diets and I had to check em both because not 
always what’s on one is good for the other” 
 
“Now and again I see the diabetic nurse at the doctors, but she’s 
not happy seeing me because I’ve got such a lot of complicated 
things wrong with me” (Participant 5) 
 
“Sometimes you go to one clinic and they say one thing and you 
go to another clinic and they say something entirely different and 
you think to yourself well what am I doing wrong, and then of 
course, when you ask them a question they say oh right, and you 
tell them I’ve been to this clinic and they said this, they say well 
stick to that” (Participant 8) 
 
“You read one thing that says if you’ve got this complaint which 
I’ve got it says eat avocado cos it’s good for you and then you 
read something else and it says don’t eat avocado so you know it 
can be a bit of a trial at times” (Participant 10) 
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Table 15 (Continued) 
 
Empowerment 
- biomedical  
 
A common theme was the lack of 
sharing of biomedical results between 
HCP’s, particularly GP’s and patients. 
Participants were not informed of 
results and there is the suggestion 
that when results were not shared 
with the participant that this lead to 
the assumption that the test result 
were positive/good and didn’t require 
action. For some participants they felt 
that the course had prompted them to 
ask more questions of their GP 
regarding biomedical results. 
“I’ve come to realise that as a result of that course, we had a 
blood test taken and my readings were not very good and of 
course I had had quite a number of blood tests where my doctor 
had said they were steady, they were okay, but they were worse 
than the readings that I’d had here, when I’d been called back for 
another blood test.” (Participant 6) 
 
“I just had to do another blood test, we’ll have another blood test, 
so they did another blood test and I was okay, I wasn’t called in 
for anything. I wasn’t told anything so, you know it’s what you do, 
if you don’t hear anything back, you think it’s okay, which it 
probably is.” (Participant 3) 
 
“I mean my GP just did these tests and he didn’t tell me and then 
he just started doing these test for eGFR. I said what’s that, I had 
to go online to find out” (Participant 5) 
 
“[The course] prompted me to go back and ring me GP up and 
get me last readings, because they’re not very good at 
communicating that really, I mean I have blood tests here every 
four months, but I don’t ever get feedback unless there’s 
something wrong, I just take it well you know if I haven’t heard 
anything then that’s alright, but it did prompt me , and it’ll probably 
prompt me in future, cos I get me blood tested every time I come 
and I only see me own GP once a year, it will prompt me to ring 
them up and get confirmation of what the results are.”  
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Table 15 (Continued) 
 Reality 
 
A small number felt that the session 
brought home the severity of DKD. 
One participant described how the 
module emphasised the seriousness 
of the condition, and the detailed risk 
factors combined with his lifestyle 
resulted in a realisation which 
affected his SE. He describe a 
preference to receive information 
prior to prepare for the content.  
“[It was the] starkness of when you see, like for me, when I ticked 
all the boxes, and like I said earlier, I’d probably been told but it 
didn’t register, that I’m in serious trouble in effect. It’s that, and 
that deflected from some of the content for the session…I did feel 
rubbish about meself” (Participant 4) 
 
“Looking back, I realised I went very quiet and within myself 
because it hit home to me rather starkly where I was, so I found 
that very hard and very difficult, and I’ve struggled with it since, in 
fact what happened with me when I worry about things I eat, so a 
consequence from that, rather than it helping me, because of me, 
I finished up, I’ve put on quite a lot of weight since that event” 
(Participant 4) 
 
Another participant described how he 
had not had very much information 
from his GP about his DKD, and 
described his surprise at having been 
invited to participate in the education 
session. 
“I received it out of the blue, an invitation, I’m not sure but I think 
because information must have come here from my GP and I’d 
had some information that I had some dysfunction with my 
kidneys, but nothing very much and it was a bit of a surprise 
really… 
 
“There’d never been a focus at the surgery on a kidney 
dysfunction. All that happened was, I had a blood test and I got 
called in, you know, come and see the doctor, and I was told my 
kidney was showing up some negative stuff and that was that. 
And then after that I get called to this” (Participant 3) 
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Table 15 (Continued) 
 
Further 
Support 
 
When asked whether they would 
benefit from further support, many the 
majority felt they received adequate 
support from routine appointments 
with HCP’s. However, a common 
theme was living with multiple LTCs 
and felt they could benefit from more 
tailor-made practical advice to help 
them to make healthy lifestyle 
choices.  
“I tell you what there isn’t enough is diet sheets, and I don’t mean 
information that you should be on a diet I mean you know putting 
diet sheets and have two diet sheets together especially for 
kidneys, where you’ve got one for low potassium, and one for you 
know, the sugar diet, the diabetes ones, so issuing everybody 
with two of those would be a good idea I think.” (Participant 2) 
 
Others recognised changes in 
management can occur therefore 
warranting additional information and 
future education and to reinforce 
previous education and share new 
advice. 
“Well I just hope they repeat it, if they’ve got the resources to do 
it, I think this is quite a forward looking unit to be honest and I 
hope they repeat it, if I’m honest with you. You know I’m not 
saying do them every six months or whatever but once a year or 
once every eighteen months or whatever just to kind of remind 
people” (Participant 10) 
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Table 15 (Continued) 
 
Further 
Support 
 
The participants who had found the 
session difficult to process due to 
realisation of his risk factors and the 
implications for his health, suggested 
that he would benefit from follow up 
sessions, delivered on an individual 
basis. Again the importance of 
support, not only from clinicians but 
social support is highlighted in the 
inclusion of his spouse in being able 
to utilise further support.  
 
“Yes it would be 1-1 sessions. The session that we had was 
good, there was four of us, so for that type of event that was spot 
on, but for me now to move forward I really feel as if I need some 
one to one or one to two with me and my wife, that would possibly 
help” (Participant 4) 
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5. Discussion  
5.1 Summary 
This research indicated that a standalone DSE disease-specific module has a positive 
impact on patient self-care, represented by improved knowledge, and significant increased 
levels of SM and SE related to DKD management. This is reinforced by qualitative findings 
which demonstrate the positive impact of the module, which provides supporting evidence 
of actual changes as a result o the module. 
The results illustrate the need for partnership between HCPs and patients to aid 
understanding and management of DKD. Qualitative findings highlight the lack of 
communication from HCP in sharing information pertinent to DKD results, while the 
quantitative findings show an increase in patient SE and SM in relation to biomedical 
results once they are made aware of the biomedical tests in DKD and the Implication of 
these.  The importance of social support is evident through quantitative findings showing 
significant strong correlations between SE and SM in relation to sharing of worries and 
seeking helping from family and friends and which is further emphasised by qualitative 
finding showing the positive and negative implication of support depending on the support 
available or lack thereof, on patients SM.   
The three month follow-up period was sufficient to demonstrate that ask time from 
education progresses, a decline in knowledge is demonstrated. This is also supported by 
qualitative findings which suggest that potential awareness of the SM activities were 
known to the patients prior to the intervention, with the education acted to reinforce this 
awareness and as a result prompt re-engagement or initiation of SM activities.  
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5.2 Participant’s characteristics  
The majority of the participant population (92%) had T2DM; which reflects the national 
average of approximately 10% and 90% for T1DM and T2DM respectively (Diabetes UK, 
2014). Table 16 highlights that the study cohort represents a well-managed DKD 
population, given median biomedical results for HbA1c, BP and cholesterol shows optimal 
control is achieved in the majority of the cohort. This is further emphasised when 
consideration is given to the percentage to the local population who achieve treatment 
target  
 
Table 16: Percentage of people with diabetes who achieve treatment target in NHS 
West Cheshire and median values (IQR) for biomedical measures of the study 
cohort 
 
1Percentage of people with diabetes in West Cheshire locality achieving treatment targets 
(Source: Health and Social Care Information Centre, 2014) 
 
The National Diabetes Audit (NDA) identified that older adults with T2DM have the highest 
levels of achieving treatment targets (Health and Social Care Information Centre, 2014). 
While those in the 65 to 79 years age range for T1DM and T2DM are more likely to receive 
  
Measure Target West Cheshire1 Study cohort 
HbA1c <58 mmol/mol 66.4% 56 (55-64) mmol/mol 
Blood 
Pressure 
≤140/80 mm Hg 73.6% 140/71 (119-152/64-82) mm Hg 
Cholesterol < 4mmol 44.2% 3.90 (3.35-4.25) mmol 
All measures All of above 41.5%  
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all eight care process identified by NICE guidelines which includes measurement of 
HbA1c, BP, cholesterol, urine albuminuria and serum creatinine  (NICE, 2004; NICE, 
2008).  
 
When this is compared to the study population, it suggests the participants are those most 
likely to be receiving healthcare essentials and more likely to be achieving treatment 
targets, given 92.3% had T2DM and the median age was 70 years (IQR 61.2-78.5 years).   
 
Access to diabetes healthcare essentials is an important consideration as research 
suggests that this practice leads to greater likelihood of treatment target achievement 
(Persell et al., 2010). A cross sectional study found that those who received cholesterol 
and microalbuminuria testing, and a foot examination had better HbA1c results (Persell et 
al., 2004). It must be acknowledge that the authors categorised better HbA1c as 9.5% (80 
mmol/mol) or less, which is higher than current treatment target  of <58 mmol/mol (7.5%). 
However, it does suggest that better HbA1c control, albeit not optimal control is achieved 
in those receiving more of the healthcare essentials. 
 
Given the chronic progressive nature of diabetes, access to the healthcare essentials may 
hold understandable benefits given that the changing dynamic of diabetes often 
necessitates continuous monitoring, hence the fifteen healthcare essentials (Diabetes UK, 
2011) and adjustment of management practice in order to identify when current 
management no longer suffices, to aid achievement of optimal control. 
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5.3 Impact of education on SM 
5.3.1 Biomedical results  
An area of significant change in the current study was in relation specifically to the 
biomedical measures of the healthcare essentials. Both SE and SM activities related to 
understanding and asking the meaning of blood and urine results demonstrated significant 
improvements. Considerable focus was given to this in the QI (for examples see Table 15 
section “Empowerment-biomedical”) 
This is a positive outcome of the study given as it shows that the education session can 
support participants to develop SM behaviours and enhance SE, which can be utilised in 
DKD self-care.  
Other research in this area suggests that knowledge regarding clinical measures results in 
better diabetes control (Polonsky, Zee, Yee, Crosson & Jackson, 2005; Beard, Clark, 
Hurel & Cooke, 2009). Education to improve familiarity and understanding of biomedical 
measures incorporated in diabetes care has been shown to significantly improve HbA1c 
and SM (Polonsky et al., 2005).  
 
Other studies contrast this and suggest that knowledge of HbA1c alone is not sufficient to 
improve diabetes SM and SE (Skeie, Thue, & Sandberg, 2001; Heisler, Piette, Spencer, 
Kieffer, & Vijan, 2005). Heisler et al., (2005) found that good communication with HCP’s 
and higher levels of formal education background were associated with better laboratory 
measured HbA1c. While Skeie et al., (2001) found that those who self-report better 
knowledge about HbA1c are those who have longer duration of diabetes and preform 
greater self-monitoring of blood glucose, which is proposed to be as a result of greater 
levels of knowledge accumulation through years of diabetes management. In contrast to 
Polonsky et al. (2005) no difference in actual HbA1c was found for those who reported 
higher or lower levels of general HbA1c knowledge (Skeie, et al., 2001). This study did not 
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investigate how accurate participants self-reported HbA1c was compared to their actual 
laboratory measured HbA1c value via comparison to medical record. This would add extra 
value to the study as it would identify whether a relationship exists between reported 
knowledge and a relatively unbiased biomedical result exist, rather than relying on self-
reported results which may be incorrect.  
 
Overall this research suggests that in isolation knowledge of HbA1c is insufficient to 
impact actual results, however combined with education to improve knowledge, SE and 
SM skills and in partnership with HCP, it can improve HbA1c outcomes (Beard et al., 2009; 
Heisler et al., 2005; Polonsky et al., 2005. Skeie, et al., 2001). 
 
This is a consideration of recent national incentives which encourage awareness and 
understanding of targets in order to support SM (Coulter, Roberts, & Dixon, 2013). The 
NHS Year of Care model aims to create a partnership between the HCP and the person 
with diabetes (or other LTCs) to aid SM (Coulter et al., 2013). This has positive cost 
implication for the NHS (Wanless, 2002) and provides individuals with the support to 
increase their confidence in self-care (Coulter et al., 2013).  
 
A value of the present study is that the module encourages engagement with receiving the 
diabetes healthcare essentials outlined by Diabetes UK (2011) particularly in relation to 
DKD, namely HbA1c, BP, lipid profile, microalbuminuria and eGFR. The may be a benefit 
of this education, considering participants show a significant improvement in 
understanding of the laboratory results, and increased confidence in asking the meaning of 
blood and urine test results emphasised by qualitative findings which suggest participants 
are more likely to ask for and discuss results with their HCP (Table 15).  
87 
 
The measurement of long term changes in clinical outcomes measures were not permitted 
in the current research. However the research outlined above, suggests that awareness of 
targets can be an aid to progressing actions of self-care into improvements in metabolic 
outcomes.  
 
 
5.3.2 Correlation between outcome measures 
Interestingly there were no corrections between SM “ask the meaning of your blood and 
urine test results” with SE “I can understand the meaning of the CKD-related blood & urine 
results” despite both independently showing significant improvements. Similarly neither of 
these SM or SE variables showed any relationship with total knowledge scores despite 
individual knowledge questions relating to BP and GFR showing improvements through 
the education session.  
The present study was able to demonstrate improvement in SE and SM specific to 
following dietary recommendations, seeking resources to aid CKD management and 
discussing experiences, problems and concerns with family members and friends. Further 
to this a strong positive correlation were found between SM and SE related to following 
dietary advice. This is in keeping with other studies into SE and SM behaviours in diabetes 
and CKD which show individuals with higher levels of SE have higher levels of SM 
behaviours (Al-Khawaldeh et al., 2012; Curtin et al., 2008; Knight et al., 2006). Al-
Khawaldeh et al. (2012) demonstrated correlations between diet, exercise, blood sugar 
testing and medication taking SM behaviours and SE with respect to these behaviours; 
this study did not explore biomedical results. This suggests self-care requires an emphasis 
on empowering people with diabetes to aid the SM actions.  
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Interestingly Steed et al., (2005) examined outcomes from a three month education 
intervention, and found that education resulted in improvement in exercise and blood 
glucose monitoring SE and these two factors had the greatest change in SM behaviours. 
This is a similar relationship in different areas to the current research, however no 
correlation outcomes between SE and SM behaviours was presented by Steed et al., 
(2005).    
 
In the current research, it would be useful for the intervention to promote a greater degree 
of partnership in care-planning and questions around treatment, particularly if it is aids 
adherence to the treatment plans.  Care plans for diabetes are multi-factorial and complex, 
differing for each individual and with difference circumstances for each person. McNab 
(1997) identified problems in adherence including multiple SM behaviours, required on a 
daily basis, potentially alongside other health conditions and also a lack of specific 
instruction on targets from HCPs. The present study suggests some improvement has 
been made, represented by correlation between seeking information about CKD and 
asking HCPs about current medical condition, and further supported by the QIs, for 
example, 
“[The course] prompted me to go back and ring me GP up and get me last 
readings, because they’re not very good at communicating that really” 
This suggests that improvements in SE and as a result SM behaviours have been 
achieved, with similarities to other research in the area but present inconsistencies in 
certain areas regarding to the relationships between certain SE and SM activities.  
 
The present study also, found no correlation between either of the SM behaviours seeking 
information or using different means of clarifying questions with the SE measure contact 
HCP to seek advice. Curtin et al., (2008) identified weak correlations between SE and 
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elements of SM behaviours relating to communicating with HCPs, seeking out sources of 
information and daily practical self-care activities. No correlation was found with self-
advocacy which was related to seeking a second opinion and asking for improvements or 
change to regimes (Curtin et al., 2008). Curtin et al. (2008) suggest that self-advocacy as 
described in their questionnaires, is of least relevance to individuals with CKD. However, 
perhaps it is a reflection of health care provision that the HCP “knows best” and as such 
individuals may be less likely to question practices. 
 
 5.3.3.1 Partnership   
Improvements in SM and SE were demonstrated in actively seeking information about 
CKD and seeking resources to better control CKD as well as significant moderate positive 
correlations between these SM activities and their SE counterparts (Table11). This is a 
valuable outcome as it suggests that a partnership can be created. This is compatible with 
the self-care nature that structured education should support and also the partnership with 
HCP’s that the NHS is keen to establish (NICE, 2003; DoH, 2010).  
 
The participants also identify the need for greater awareness among HCP about long term 
conditions (LTC’s) in order to support individuals to manage and combine care to aid care 
plans and priorities of different conditions. This is an area where HCP may have to take an 
extra element of responsibility to aid self-care, which may involve learning of other health 
concerns and how to structure care plans which combine other potentially unrelated 
conditions.   
Sometimes you go to one clinic and they say one thing and you go to another 
clinic and they say something entirely different and you think to yourself well 
what am I doing wrong, and then of course, when you ask them a question they 
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say oh right, and you tell them I’ve been to this clinic and they said this, they 
say well stick to that”  
 
The implication of a growing population with multiple comorbidities (Barrett et al., 2012) is 
an area that the NHS acknowledges as requiring newer structures for service provision 
(DoH, 2010). May, Montori, & Mair, (2009) highlight that multiple LTC can result in 
individuals managing multiple medications, self-monitoring, and consideration of diet and 
lifestyle priorities combined with time and effort to attend multiple separate clinical 
appointments. Lack of consideration and appropriate patient centred care plans can result 
in medication regimes that individuals cannot appropriately manage, potential adverse 
drug interactions or side effects and non-adherence by the individual as a result (May et 
al., 2009).  
 
This current intervention combined two chronic conditions, however it is acknowledged 
that other LTCs can also be present and this will affect individual’s priorities and 
management strategies which is an important consideration for all HCPs.  
 
5.3.3.2 Social support 
A value of the QIs was in highlighting that social support and in particular family support, 
has a substantial impact on participants sense of SE and SM activities, with positive and 
negative implications depending on the nature of the support available. Participants who 
had the support of family members identified the positivity this had on their ability to make 
changes, through encouragement, motivation and in one instance the completive nature of 
maintaining changes    
“With the help of my wife, I know how to look after my diabetes.”  
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In contrast to this barriers to changes were also demonstrated through lack of support. 
These participants suggest that they are challenged to make the necessary behavioural 
changes due to the negative implications of those close to them, for example,  
 “I’m not actively thinking about it [making behaviour change]. If my wife was 
more actively involved, and that sounds like a cop out really, but there would be, 
I would feel that would be a real step forward.” 
 
The quantitative results show no change in SE or SM skills in relation to seeking support 
or discussing frustrations or worries with family or friends. Further to this a moderate 
correlation was found between these variables (Table 12). These findings combined would 
suggests that those who feel they can discuss feelings or problems with others are those 
that do so; while those who do not feel they can discuss issues with their social network, 
do not feel empowered to do so as a result of the intervention and therefore remain unable 
to engage with others. The qualitative results would suggest that this does have an impact 
on participant’s actions and participants suggest beneficial effects of social support for SM.  
This is a learning point for the current education intervention, as the module did not 
incorporate significant consideration of gaining support from family members or actively 
encouraging engagement from those who would affect management skills, negatively or 
positively. The invitation to bring a second person to the group was offered and the 
encouragement of making practical changes suggested involving family members for 
support purposes. Potentially the intervention needs to extend further in this area to aid 
participant SE towards discussing support from their social network and methods of 
encouraging positive support. Overall, this would highlight the need not only for the 
individual with DKD to be involved in structured education but also their immediate support 
network, given the influence they hold.  
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A systematic review of the literature in this area suggests that social support does affect 
SM practices and diabetes outcomes (van Dam, van der Horst, Knoops, Ryckman, 
Crebolder, & van den Borne, 2005). The review found that group consultations 
incorporating a three monthly group diabetes review and education with the physician did 
improve HbA1c and lifestyle practices (Tranton et al., 2001). Peer support groups 
incorporating diabetes education and continued social support for 18 months delivered 
improved knowledge and QoL and less stress. This was in addition to the improvements 
seen in a diabetes education alone intervention which demonstrated improved diabetes 
control, less stress and greater involvement of family (Gilden, Hendryx, Clar, Casia, & 
Singh, 1992). The one study identified to access the role of family support specifically was 
measured in a weight loss and lifestyle behaviour intervention aimed at identifying the role 
of spouse involvement in an obese T2DM population over 18 months (Wing, Marcus, 
Epstein, & Jawad, 1991). The study identified that for male participants better outcomes in 
weight loss were achieved without the support of spouses, whereas the opposite was true 
for females (Wing et al., 1991).  
 
It is evident that all of these interventions are much more intensive than the current 
research; however of interest is that the authors conclude that mechanisms from the 
individual studies could provide effective strategies for improved support (van Dam et al., 
2005). This could include effective diabetes group education, better organisational deliver 
of care and enhanced interactions between HCP’s and people with diabetes. Overall it is 
acknowledged that greater research is warranted in the area and that support may need to 
be adaptable to the individuals’ needs and what they need or desire from support 
structures, considerate of family, peer or professional support (van Dam et al., 2005).  
The current study suggests that family support is important to this cohort and it is 
acknowledged that this may be a barrier to change or an effective enhancement of self-
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care depending on whether there is negative or positive support available. It is an 
important consideration which should be utilised in consultations with individuals in order 
to identify a self-care plan which is considerate of the implication of the support or lack 
thereof, in each individual case.  
 
5.3.3 Correlation with knowledge 
Similar to the present study, multiple other sources have reported the benefits of education 
in improving knowledge (Deakin et al., 2005; Knight et al., 2006; Mason et al., 2008; Stead 
et al., 2005). This has value as without knowledge, people have no reason to change. In 
theory, individuals require increased knowledge to improve management of their condition, 
however as stated earlier improved knowledge through diabetes education has not been 
shown to result in improved biomedical outcome measures unless the actual principles of 
education are implemented and maintained by the individual (Gomersall et al., 2011). This 
lack of improvement in HbA1c is potentially due to a lack of implementation of new 
knowledge in the form of necessary behaviour changes. It is proposed that the areas of 
knowledge, SM and SE are all required in order to improve HbA1c (Al-Khawaldeh et al., 
2012). Stead et al. (2005) demonstrated improvements in knowledge, and limited 
improvements in SE related to exercise and blood glucose monitoring and SM behaviours 
related to diet, exercise, blood glucose monitoring and foot care. This was accompanied 
by a trend towards improvements in HbA1c at three months post intervention. The authors 
do emphasis that the study population did not have particularly high HbA1c measure at the 
onset of the study (67± 51- 84 14 mmol/mol; 8.29 ± 1.5%) therefore making it more difficult 
to show improvement.  
Other research shows there was a no association between knowledge and receiving the 
diabetes healthcare essentials HbA1c, cholesterol and urine micoalbuminuria screening or 
foot examinations (Persell et al., 2004). The authors suggest that people who access 
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education are assume to have accessed the diabetes healthcare essentials, by virtue of 
being more knowledge and potentially that those providing the education are assumed to 
ensure the provision of these measures (Persell et al., 2004).  
Many studies have identified improvements in SM activities in relation to diabetes 
management, yet this has not been reflected in long term improvements in biomedical 
outcomes (Al-Khawaldeh et al., 2012; Davies et al., 2008; Stead et al., 2005) and perhaps 
Persell et al. (2004) has highlighted a gap in current education provision that needs to be 
addressed in order for self-care activities to translate into biomedical outcomes that has 
the potential to change long term outcomes. Given the chronic progressive nature of 
diabetes this may hold understandable benefits; the changing dynamic of diabetes often 
necessitates continuous monitoring, hence the fifteen healthcare essentials (Diabetes UK, 
2011) and adjustment of management practice in order to identify when current 
management no longer suffices, to aid achievement of optimal control.  
 
Clinically, HbA1c is central to optimal diabetes management given its significance in long 
term management and risk management (DCCT, 1993) however it has been found that 
individual understanding of this biomedical measure in poor (Beard et al., 2009).  As 
discussed earlier understanding of biomedical information, particularly HbA1c may play an 
important role in improving diabetes control (Beard et al., 2009), however consideration of 
education, communication with HCP, social support and potentially self-monitoring of 
blood glucose were also identified as important (Heisler et al., 2005; Skeie, et al., 2001; 
van Dam et al., 2005). This necessitates the need for multiple components to optimise SM 
and this is acknowledged as major implication in diabetes (McNabb, 1997). As a result, it 
is suggested that patients are non-adherent to care plans, however it should be 
acknowledge that the multi-nature approach to diabetes management may mean 
adherence in certain, yet not all SM activities. A recognition of the changeable nature of 
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diabetes, both in relation to daily activities and long term management plans needs to be 
expected and care plans should be generated in partnership between patients and HCP, 
with an emphasis on collaboration to strategize for this  (McNab, 1997). 
 
5.3.4 The need for continued support 
It is worth considering that only 53.8% of participants reported receiving prior diabetes 
education and for a large proportion 42.9%) this education was over five years ago (Table 
4). Potentially a proportion of the 30.8% who denied previous structured diabetes 
education may have actually received impromptu education, for example information 
received from clinic appointments. This is suggested given the qualitative feedback 
suggests that a level of knowledge was present prior to the education session and that 
many messages were reinforced. 
 
This population have had DKD for a substantial period of time and yet benefits are 
demonstrated from the intervention, this suggests that repeated exposed to education has 
beneficial effects. Consideration of this, alongside the quantitative outcomes related to 
knowledge, further emphasis for the need for continued and ongoing educational support.  
 
An Improvement in knowledge as a result of the education was demonstrated and this 
improvement is retained to different degrees at week twelve. As discussed previously, the 
peak of knowledge improvement is immediately post intervention, with retention reducing 
by twelve weeks post intervention. At twelve week, 62.5% of results are higher than at 
baseline but not as high as they had been immediate post-intervention.  This shows that 
as time from intervention progresses, knowledge is reduced however remains higher than 
baseline in the majority of cases. This is a factor supported by other similar research 
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(Stead et al., 2005) and highlights the value of the need for access to regular DSE as 
encouraged by national guidelines (NICE, 2003),  
 
NICE (2003) emphasis the need for education on an ongoing basis based on individual 
need and considerate of changes over time. While quality standard 6 of NICE (2011) in 
relation to diabetes education identified the need for access to DSE at diagnosed and on 
an annual basis.  The current education would be suitable for those who develop DKD and 
would allow for more tailored education to individual need, while also being considerate of 
changes over time. DSE is deemed by NICE (2003) as being cost effective given the 
impact it can have on diabetes control, QoL and long term outcomes.  
 
It is proposed that this standalone module was sufficient to provide the information 
sufficient to meet the needs of the population, demonstrating positive outcomes in many 
areas, without asking for greater commitment such as a course of sessions delivered over 
a number of days or weeks. Although HCP can see the worth in more elaborate and more 
intensive input, this may not be compatible with certain patients and results in reduced 
uptake and greater attrition, this has been demonstrated in courses targeting similar 
populations with a greater time commitment over multiple visits (Steed et al., 2005).  
 
5.4 Strengths 
The dual methodology of the study allows quantitative analysis of standardising 
questionnaires to investigate changes over time combined with QIs to add greater depth 
and robustness to the findings and give a fuller understanding of the outcomes.  The 
qualitative element by nature of the semi-structured QIs allow for factors that affect the 
participants, but not considered by the researchers to be identified and analysed in the 
research. This offers an extra dimension to the study in terms of the multifactorial 
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approach that is DKD self-care and is considerate of NICE guidelines to incorporate this 
type of research to aid the identification of factors important to patients (NICE, 2003).  
 
5.5 Limitations 
5.5.1 Sample size 
As previous acknowledge the recruitment numbers and time scales was a limiting factor 
for the study, considerate of the resources available for this Master’s degree project. A 
criticism of the sample size is that it may be under powered to detect significant change. 
However the design of the study in using the mixed methodology approach does add extra 
merit to the results.  
 
5.5.2 Questionnaires 
There are also limitations of the questionnaires used; both the CKD-SE and CKD-SM are 
new measurement tools which have not been used in repeated measure studies 
previously. Considering the participants rated on the higher range in the majority of scores 
at baseline, the tools then became limited in their ability to convey whether positive 
changes resulted from the intervention. A “ceiling effect” may have been created due to 
the tools used; this is, the initially score is so good that improvements are hard to detect. 
Potentially using scales which were able to convey positive, negative or lack of change as 
a result of the intervention would have been more enlightening. Once such questionnaire 
for the assessment of SM behaviours is the Revised Summary of Self-Care Diabetes 
Activities Measure (Toobert, Hampson & Glasgow, 2000) which has been utilised 
previously in education intervention in people with T2DM (Steed et al., 2005; Al-
Khawaldeh et al., 2012). This took has been shown to have acceptable internal 
consistency, test-retest correlation and no issues with ceiling effect reported in other 
studies.  
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Similarly, the Diabetes Multidimensional diabetes scale (Talbot, Nouwen, Gingras, 
Gosselin, & Audet, 1997) could have had benefits over the CKD-SE questionnaire. It 
measures SE, diabetes and social support perceptions and behaviours of self-care. It has 
demonstrated good internal consistency in patients with T2DM and has been used in 
similar cohort without issues regarding ceiling effect (Steed et al., 2005).  
The additional benefit of utilising these two questionnaires is that it gives the opportunity to 
compare to the current education to interventions which have used the same tools (Al-
Khawaldeh et al., 2012; Steed et al., 2005). This may have allowed for more comparisons 
to be made between the various interventions.  
 
The selection of the CKD-SM and CKD-SE questionnaire was to incorporate specific 
questionnaires linked to CKD in order to consider the CKD element of the condition. It is 
acknowledge by Mason et al. (2008) that there is a lack of CKD specific questionnaire and 
that the development and use of such questionnaires should be supported. However this 
should be considered alongside the fact that the CKD-SE tool was relative recent and did 
require further interventions to identify its ability to detect change over time allowing it to be 
used in the evaluation of interventions (Walker & Buchbinder, 2012). The use of it in this 
current study suggests that its use in detecting change may be limited. However, the 
benefit of using the current questionnaires is that the elements were deemed pertinent to 
the behaviours that were desirable outcomes from the intervention and they were allow 
further investigation through the QIs, given further strength to the study outcomes.  
 
In the completion of the KiKS there is an increase in no responses at week 6 and the 
reason for this is unknown. Potentially it is the design of the study that reduced responses, 
week 6 was the only point where qualitative and quantitative elements coincided. Visit 1 
incorporated baseline data collection, the education intervention and the post education 
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visit therefore carrying the greatest time and study burden, yet non-responses were much 
lower. Week 6 had the same strategy for questionnaire completion as baseline; however it 
could be speculated that the QIs carried a substantial participant burden that potentially 
reduced their desire to complete the additional questionnaires appropriately. Perhaps the 
manner of completing the questionnaires at home (week 12) was preferred over the 
completion at the study site (week 6) as it allowed greater compatibility with participant’s 
needs, e.g. time and comfort.  
 
5.5.3 Sample composition 
A positive of this research project is that the lack of attrition of the study population over 
the intervention period, which reduced biases which could have occurred should certain 
participants have been lost to follow up. As acknowledged earlier Steed et al., (2005) 
showed in a similar study population that those who did not complete the study were those 
with a higher baseline HbA1c. This suggests that those who partake in research are 
potentially those who are more motivated to engage and see the benefit of the 
intervention. This leads to the proposal that in this current cohort, it may be those more 
willing to engage or who are already engaged with the SM advice who agreed to partake, 
and this is reflected in the biomedical achievements of this cohort as discussed earlier 
(Table 1).  
As described previously, the study sample lacked ethnic diversity which reduces the 
generalisation of the study findings to the wider population.  
The median duration of DKD in this population was 7 years (IQR 6-7 years), therefore this 
is not a new condition for this population. As discussed previously, research does suggest 
that those with greater knowledge are those who have had a longer duration of diabetes 
which is thought to be related to accumulation of information (Skeie, et al., 2001). Also 
Norris et al. (2012) identified that greater contact time with HCP’s was associated with 
100 
 
better diabetes control. Both of these studies would support the possibility that longer 
duration and engagement with HCP’s leads to better control, which may be reflected in the 
current cohort.  These findings would suggest that the potential exist for a greater impact 
of this type of education at an earlier stage of diagnosis as individuals will have had less 
contact with HCP’s. 
 
5.5 Implications of the results 
The study adds to research in DSE specifically for DKD and demonstrated the benefits a 
compact standalone module can have on patient outcomes.   
Education is a well-accepted standard of DSE and this study supports the use of education 
in DKD. It is acknowledge that not all SM and SE variable showed improvements in the 
current population, however it is proposed that the changes demonstrated as a result of a 
two hour DSE intervention, were substantial enough to be clinically beneficial as part of 
routine clinical care.  
 
The NHS is encouraged to make available group DSE on a regular basis and considerate 
of ongoing needs of the patients (NICE, 2003). Given the progressive nature and 
increased risk of CKD in people with diabetes (Hippisley-Cox &Coupland, 2010), offering 
tailored education allows for education to meet the changing needs of the population. This 
study demonstrated the positive outcomes of such intervention on patient self-care and 
emphasis that as time from education progresses so too does knowledge and SM, 
therefore access to education on a regular basis is supported.  
 
Extending the outcomes of the research to clinical care, suggests the need for awareness 
of HCP of the importance of social support to aid patient self-management, and the 
negative implication of SM and lack of ability to implement SM care plans if such support is 
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not available . Partnership between HCP and patients is also of importance as the study 
demonstrates that sharing of information by HCPs can be lacking. However with 
appropriate education and sharing of information between patient and HCP, SE and SM 
improves, and previous research suggests this may aid overall control (Polonsky et al., 
2005) 
 
Future research  
The current study population represent a well-controlled cohort, who were more likely to 
have the access to the diabetes healthcare essentials which could implicate a greater 
degree of input by HCP’s and awareness of their condition (Health and Social Care 
Information Centre, 2014; Persell et al., 2010). It would be interesting to repeat this study 
in a population with a relatively recent diagnoses of DKD as a way of aiding management 
of the condition prior to the need for escalation to specialist secondary care service, given 
the major role of diet and lifestyle in the management of DKD in delaying the progression 
of DKD (Gaede et al., 2003) and also considerate that earlier interventions are proposed to 
aid management of DKD in the long term (Mason et al., 2008). This is considerate of the 
manner in which the NHS is directing current service provision by facilitating greater 
ownership of LTCs by patients in primary care practice (Coulter, Roberts, & Dixon, 2013). 
 
Secondly, it would be useful to explore the potentially reasons for the lack of correlation in 
the current study further in order to identify reasons for a lack of correlation between SE 
and SM. In the studies discussed, each uses different self-completed questionnaire to 
identify levels of SM and SE, and this potentially affect the outcomes. The questionnaires 
used in the present study may be a limitation to identifying correlations as both measures 
had outcome values on the higher side of the scale and a ceiling effect of both 
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questionnaires is proposed as a result of high values at baseline. This limitation is 
considered further in the limitation section.   
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Conclusion  
The present study shows a benefit in improving knowledge related to CKD, alongside 
certain SE and SM behaviours important to DKD management. The study cohort was a 
relatively well controlled group represented by a median HbA1c within treatment target and 
high levels of SE and SM at baseline.  
However, notwithstanding this, the intervention successfully improved aspects of DKD 
important to effective SM. Previous research identified the role of these SM practices in 
risk reduction and delayed progression of DKD (Gaede et al., 2003; Mason et al., 2008). 
SM improvements were demonstrated in dietary adjustments, seeking support, and asking 
about biomedical results. Previous research has demonstrated positive effects on diabetes 
control, hypertension and dyslipidaemias as a result of improvements in these factors 
(Delanhanty & Halford, 1993; Gaede et al., 2003; Polonsky et al., 2005; van Dam et al., 
2005).  
Similar to other research in the area of DSE no correlation was found between knowledge 
and SM (Gomersall et al., 2011). Therefore this study adds to the evidence that increased 
knowledge does not correlate in improvements in SM and as a result education providers 
need to ensure education is in the format to support SE and SE, rather than purely 
knowledge focused.  
Qualitative findings emphasis the practical daily SM participants have instigated or 
improved upon as a results of the education and strengthens the likelihood that 
improvement are being made in SM behaviours.  The QIs identify the need for positive 
social support to enhance SE and progress SM. They emphasise that a lack of support 
impedes SM which should be an important consideration of SDE.  Potentially, initial SM 
care plan need to Identify social support, develop engagement of family members and 
work to resolve negative social support if evident.  
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 To conclude a DSE disease-specific module for DKD has positive implication for patient 
care, in terms of SM, SE, knowledge and overall patient experience. The module is 
consistent with national guidelines to provide appropriate, ongoing education in a manner 
compatible with engaging participants in self-care, which is an important endeavour of 
current NHS strategies (Coulter et al., 2013; NICE, 2003).  
 
Further research into the effectiveness in newly diagnosed DKD is warranted as evidence 
suggest the modules may have the potential to have a greater impact in primary care, 
where newer diagnosis and an earlier emphasis on self-care may reduce the disease 
progression and delay the use of specialist secondary care services (Mason et al., 2008; 
Norris et al.,  2012) 
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Appendix 3 Consent Form (Quantitative Research)   
                         
 
   PARTICIPANT CONSENT FORM 
 
Title of Project:  Diabetes Essentials Kidneys: Does education improve outcomes 
   A modular approach to Diabetes structured group education: 
The effects of Diabetes Essentials: Kidneys on patient knowledge, self-
efficacy, self-care behaviour and patient experience.   
  
Name of Researcher:  Susan Gallagher 
                                                 Please INITIAL 
box 
 
1. I have read and understand the patient information sheet for the above study. I have 
had the opportunity to consider the information, to ask questions and to have these 
answered satisfactorily. 
 
2.   I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being affected. 
 
3. I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by individuals from the hospital, and from individuals within the 
hospitals Research & Development office. I give permission for these individuals to 
have access to my records. 
 
4. I understand that my data will be held on a computer at the hospital. I give my 
permission for this data to be held on computer by this party. 
 
5.  I agree to take part in the above study. 
 
 
 
________________________ ________________ ____________________ 
Name of Participant   Date Signature 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
 
When completed; 1 for participant (copy); 1 for researcher (original); 1 to be kept with hospital notes (copy)  
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Appendix 4 Consent Form (Qualitative Research)   
                         
 
    
PARTICIPANT CONSENT FORM: PART 2 
 
 Title of Project:  Diabetes Essentials Kidneys: Does 
education improve outcomes 
   A modular approach to Diabetes structured group 
education: The effects of Diabetes Essentials: Kidneys on 
patient knowledge, self-efficacy, self-care behaviour and 
patient experience.   
  
        
  Yes No 
1 I confirm that I have read and understood the information sheet 
for the above study.  I have had the opportunity to consider the 
information, ask questions and where necessary, have had 
these answered satisfactorily.         
  
2 I am willing to participate in an interview   
3 I am willing to have the interview recorded.   
4 I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving any reason. 
  
5 I understand that my responses will be anonymised and my 
identity will not be revealed during the study or in any reports or 
publications. 
  
6 I understand that my direct quotes may be used in reports or 
publications however responses will be anonymised and no 
identifiable information will be used
  
7 I understand that the researchers will hold all information and 
data collected in a secure and confidential manner. 
  
8 I understand that the data collected during the study may be 
looked at by individuals from regulatory authorities or from the 
NHS Trust where it is relevant to my taking part in this 
research. I give permission for these individuals to have access 
to this information. 
  
 
 
________________________ ________________ ____________________ 
Name of Participant  Date Signature 
 
_________________________ ________________ ____________________ 
Name of Researcher  Date  Signature 
 
When completed; 1 for participant (copy); 1 for researcher (original); 1 to be kept with hospital notes (copy) 
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Appendix 5 Participant invite letter 
 
 
 
 
 
 
 
 
Diabetes Unit 
Countess of Chester Hospital NHS Foundation 
Trust 
Countess of Chester Hospital Health Park, 
Liverpool Road 
Chester  
CH1 2UL 
 
Date  
 
No , 
X Street  
Area 
Town 
Post Code 
 
 
Dear  X 
Research Study  
Diabetes Essentials Kidneys: Does education improve outcomes? 
 
 
The Countess of Chester Hospital and the University of Chester are working together to 
carry out a research study and are writing to ask if you would be willing to take part.  
 
The study  is  investigating the  impact the group session Diabetes Essentials: Kidney has 
on the way people with diabetes manage their condition.  It  is hoped that by attending 
the  group  session  people  with  diabetes  and  kidney  problems  will  increase  their 
knowledge  of  the  condition,  be  in  a  better  position  to  manage  their  condition 
themselves and potentially  reduce  the anxiety associated with  living with  this complex 
condition.  
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Why have I been asked?  
You have been chosen because you have diabetes and your  recent blood results show 
that  you  have  kidney  impairment.  You  are  one  of  a  number  of  people  from  across 
Western Cheshire Primary Care Trust that we are asking to help.  
 
What would I have to do?  
 
If you agree to take part, you will be asked some questions about your diabetes and how 
you manage it. You will also be asked to complete questionnaires, attend the education 
session (Diabetes Essentials: Kidneys) and have a discussion with a researcher about the 
affect the education session may have had on you.  
 
It would involve two visits to the Countess of Chester Hospital. The first visit involves 
completing  questionnaires  and  attending  the  group  education  module  “Diabetes 
Essentials:  Kidneys”  (Please  note  you  will  have  already  have  received  an 
appointment  letter  for  this  education  session).  The  second  visit  (6  weeks  later) 
involves an individual discussion with a researcher to tell us more about your overall 
experience  of  the  education  session  and  how  it  may  have  affected  you.  A  third 
contact  (12  weeks  after  the  initial  education  session)  involves  completing 
questionnaires  and will  be  arranged  to  suit  your  preference  (a  telephone  call/by 
post /individual face to face contact).  
 
The researchers will cover reasonable travel expenses for all your visits. 
 
How do I reply?  
If you think you might want to know more, please register your interest within the next 
two weeks in one of these ways:  
 
1. You  could  complete  the  reply‐slip  attached  and  return  it  to  the  research 
dietitian, Susan Gallagher at the above address. A researcher will telephone you 
to discuss the study.  
 
2. You  can  telephone  the  Diabetes Unit  at  the  Countess  of  Chester  Hospital  on 
  to discuss the research further with the research dietitian.  
 
If you are  interested  in taking part the researchers will give you more details about the 
study. By contacting us you will not be under any obligation to take part, and you will be 
free to change your mind at any time.  
 
If you have any questions please contact Susan Gallagher, the research dietitian, on  
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The researchers look forward to hearing from you. 
  
Yours sincerely, 
 
 
 
Susan Gallagher 
Diabetes Research Dietitian 
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  --  --  - - - - - - - - - - - - - -   
 
Reply-slip 
 
I am interested in knowing more about the research involving Diabetes 
Essentials: Kidneys looking at education for people with diabetes and 
kidney problems 
 
 
Name:  
 
Date of Birth: 
 
Please contact me on this telephone number ………………………………… 
 
Or this telephone number………………………………………………………... 
 
Between the times of……………………………………………………………… 
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Appendix 6 Participant information sheet 
 
 
 
Version 2
 
PATIENT INFORMATION SHEET 
 
Diabetes Essentials Kidneys: Does education improve outcomes? 
A modular approach to Diabetes structured group education: The effects of 
Diabetes Essentials: Kidneys on patient knowledge, self-efficacy, self-care 
behaviour and patient experience.   
 
 
You are being invited to take part in a research study. Before you make a 
decision, you need to understand why the research is being done and what it 
would involve for you.  Please take time to read the following information 
carefully. One of the diabetes research team can go through the information 
sheet with you and answer any questions you may have. Please feel free to 
talk to your friends and family about the study.   Ask us if there is anything 
that is not clear or if you would like any more information.  Take time to 
decide whether or not you wish to take part in the study. 
 
What is the purpose of the study?  
 
All people with diabetes should have access to structured education as part 
of their routine care. The Countess of Chester Hospital NHS Foundation Trust 
offers diabetes education in the form of a once-off session known as 
‘Diabetes Essentials’.  However diabetes is a complex condition and can 
have numerous health effects on an individual. Diabetes can affect your 
kidneys and cause kidney disease (known as diabetic kidney disease or 
diabetic nephropathy). 
 
As each complication of diabetes has different effects and management 
needs, the Diabetes Unit at the Countess of Chester Hospital has developed 
education modules for specific complications. This includes an education 
session specific to diabetes and kidney disease known as Diabetes 
Essentials: Kidneys.  
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The education session will provide participants with information about the 
condition as well as information on the dietary, lifestyle and medical 
management of the disorder.   
 
The purpose of this study is to evaluate if this education (Diabetes Essentials: 
Kidneys) can improve knowledge, self-management and your confidence in 
managing your condition.  
 
Why have I been chosen?  
 
You  are  due  to  attend  the  group  education  session  ‘Diabetes  Essentials:  Kidneys’ 
because you have diabetes and your most  recent blood  results  indicates  that you 
have  kidney  impairment.  We  are  asking  you  to  take  part  in  this  research  study 
because you are due to attend this education session.  
 
 
Do I have to take part?  
 
No. It is up to you to decide whether to take part or not. Participation in the study is 
voluntary.  
 
Regardless of whether or not you take part in this research project, you are invited 
to attend the group education session Diabetes Essentials: Kidneys.   
 
We will describe the study to you and go through this information sheet. If you 
are interested in taking part we will then ask you to sign a consent form to 
show you have agreed to take part in the study. You will receive a copy of this 
information sheet and the signed consent form.  
 
You are free to withdraw from the study at any time, without giving a reason. 
Choosing to withdraw from the study will not affect the standard of your 
routine care. 
 
What will happen to me if I take part?  
 
If you decide to take part, you will be given this information sheet to keep and asked 
to sign the consent form. The study will  last for three months and during this time 
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you will be asked to attend two appointments at the hospital and to be available for 
one  other  appointment,  which  can  be  carried  out  as  a  telephone,  postal  or 
individual appointment depending on your preference.  
 
Contact 1 
You can complete and return the reply slip which is attached to the bottom of 
your invite letter, giving a suitable date, time and contact number on which 
the researcher can contact you to discuss the research further. Alternatively 
you can call the researcher to discuss the proposed research further on 
01244 363786 
If we do not hear back from you within two weeks, we will make contact with 
you via telephone to ask if you wish to participate in the research. 
Following this, if you are interested you will be provided with an appointment 
time, immediately prior to your scheduled education session in order to 
complete research questionnaires.  
Contact 2 
This contact will take place at the Diabetes Unit, Countess of Chester Hospital NHS 
Foundation Trust. At contact 2 you will have  the opportunity  to ask any questions 
you may have regarding the research. If you are happy to continue you will be asked 
to sign a consent form to consent to participate in the study.   
At this visit we will also gather some  information about you and your diabetes and 
also ask you to complete questionnaires.  
 
The  education  session  ‘Diabetes  Essentials:  Kidneys’ will  also  be  delivered  at  this 
visit. This  is an  informal group  session with approximately nine other people with 
the  same  condition  as  you.  This  session will be  delivered  by  a diabetes  specialist 
nurse.  
 
Your medical records will be looked at and if you have not had your bloods 
and urine checked in the three months previous to this visit, you will be asked 
to provide a urine and blood sample. Also if your weight and blood pressure 
have not been recorded in the previously three months, this will also be 
measured at Contact 2. If adult height is available it will be accepted 
regardless of whether it was in the previous three months. It will be measured 
at contact 2 if it is not available in medical records. 
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This whole visit (including the education session) will last approximately three 
and a half hours. 
 
Contact 3  
This contact will take place at the Diabetes Unit, Countess of Chester 
Hospital NHS Foundation Trust. 
It will involve an individual discussion with a trained researcher from Liverpool 
John Moores University. It will involve questions regarding your overall 
experience of the education session and how it may have affected you. For 
the purposes of the study it will be voice recorded.  
 
The contact will also involve completion of one written questionnaire. The 
contact will be pre-arranged at a date and time convenient to you and the 
researcher and will aim to coincide with other appointments you may have at 
the hospital if possible. It is expected to take approximately 30 to 60 minutes.  
 
Contact 4 
This will be the final contact of the study. This can be arranged by means to suit your 
preference.  It  can  be  done  as  a  telephone  consultation  with  the  researcher; 
completing written questionnaires and  returning  them by post; or as an  individual 
face  to  face  consultation  with  the  researcher  at  the  Diabetes  Unit,  Countess  of 
Chester Hospital NHS Foundation Trust. 
 
You will be asked to complete three questionnaires in relation to your diabetes.  It is 
expected to take approximately 45 minutes.  
 
What are the possible disadvantages and risks of taking part?  
 
There are no identifiable risks in taking part in this study. 
 
The  only  disadvantage  is  the  additional  time  it  will  involve  and  the  burden  this 
would  cause  for  you.  The  researcher  will  be  as  flexible  as  possible  in  arranging 
scheduled contacts and appointment time convenient to you. 
 
The cost of travelling to and from the hospital for all of the visits and  if applicable, 
parking fees, will be reimbursed to you therefore removing any financial burden of 
participating.   
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What are the possible benefits of taking part?  
 
By taking part you will be contributing to the development of the diabetes service at 
the Countess of Chester Hospital NHS  Foundation  Trust which will hopefully help 
people in a similar position to you.  
 
 
What if something goes wrong?  
 
In the unlikely event that something goes wrong as a result of taking part in 
the study, the Countess of Chester Hospital NHS Foundation Trust provides 
insurance cover and you would retain the same rights of care as any other 
patient treated in the National Health Service. 
 
If you have any concerns or wish to complain about any aspect of the way you have 
been approached or treated during the course of this study, please contact Sheila 
Williams, Research Manager Countess of Chester Hospital NHS Foundation Trust, 
Countess of Chester Health Park, Liverpool Road, Chester, CH2 1UL Telephone: 
01244 365532 
 
Any concerns or complaints can also be submitted to the Countess of Chester 
Hospital NHS Foundation Trust Patient Advice and Liaison Service (PALS) department 
by contacting 0800 195 1241,  alternatively email PALS on cochpals@nhs.net or 
write to PALS Manager, PALS, Countess of Chester Hospital Foundation Trust, 
Liverpool Road, Chester CH2 1UL. 
  
Will my taking part in the study be kept confidential?  
 
Yes,  all  information  gathered  during  the  research  study will  be  kept  confidential. 
Only  people  directly  involved  in  the  research  will  have  access  to  details  of  your 
participation.  The  lead  researcher  will  have  responsibility  for  ensuring  that  all 
information  is  kept  in  a  secure manner.  Your medical  records will  not  leave  the 
hospital.  For  the  purposes  of  analysing  and  presenting  the  final  results,  all 
information will be anonymised so participants will not be identifiable.  
A  trained  researcher  from Liverpool  John Moore University will be  involved  in  the 
project for contact 3. They will have a duty of confidentiality to you and will ensure 
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strict confidentiality. Only minimal information (and no specific clinical information) 
will  be  passed  to  this  researcher.  This  will  follow  an  agreement  between  the 
University and the Countess of Chester Hospital NHS Foundation Trust.  
 
What will happen to the results of the research study?  
 
The results will be used to help evaluate and develop the education provided by the 
Diabetes Unit at the Countess of Chester Hospital NHS Foundation Trust. They will 
also  be  used  as  part  of  a  master  level  student  research  project  and  may  be 
presented at meetings or published in a journal with interest in diabetes. 
  
Who is organising and funding the research?  
 
The Diabetes Research  Fund at  the Countess of Chester Hospital NHS  Foundation 
Trust is funding this current research. 
 
Who may I contact for further information?  
 
If you have questions or concerns  regarding participation  in  the  research, you are 
encouraged  to speak  to you GP who can give you an  independent opinion on  the 
research.   
 
If you have any question or would like to discuss this research further please contact 
Susan Gallagher (lead researcher) at the Diabetes Unit, Countess of Chester Hospital 
NHS Foundation Trust on   or by emailing  
 
 
Thank you for taking the time to read this information 
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Appendix 7 Participant questionnaire permission: KiKS   
 
 
Dear Susan, 
Thank you for your interest in the KiKS. You are welcome to use it and we only ask that 
you reference the AJKD publication if you report your findings. 
 
As for the scoring we do not weight any of the items, thus omitting 3 that you do not think 
may be relevant in your sample will be unlikely to significantly modify the properties of the 
assessment. Just rescore the remaining items as the % correct.  
  
Best wishes, 
Kerri 
  
Kerri Cavanaugh, MD MHS 
Assistant Professor of Medicine 
Vanderbilt University Medical Center 
Division of Nephrology 
Center for Health Services Research 
1161 21st Ave South 
S-3223 MCN 
Nashville, TN 37232-2372 
  
---------------------------------------------------------------------------------------------------------------- 
  
From: Gallagher Susan (COUNTESS OF CHESTER HOSPITAL NHS FOUNDATION 
TRUST)  
Sent: Friday, November 30, 2012 9:26 AM 
To: Cavanaugh, Kerri 
Subject: Kidney Knowledge Survey (KiKs) Request  
  
Dear Ms Cavanaugh,  
  
I am emailing in relation to your research into a knowledge survey for patients with CKD. I 
am undertaking my Master degree dissertation in the area of diabetic nephropathy 
education and having recently read the paper on 'Development and results of a kidney 
disease knowledge survey given to patients with CKD'.  I feel that KiKS would be suitable 
to use to determine knowledge in my proposed patient group. Would I require permissions 
or a license to use this particular survey for my research? 
  
Also there are three questions that I feel I would not expect this particular group to know 
the answer to. Would the use of the survey allow me to omit these questions? 
  
Kind Regards 
Susan 
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Appendix 8 Participant questionnaire permission: CKD-SM & CKD-SE 
 
Dear Susan, 
I sincerely apologize for delaying my reply. 
Attached please find the CKD-SE in which there presents both English and Chinese. 
Regarding the CKD-SM, the completed sentence of each item in English   have not done. 
Best wishes, 
Chiu-Chu 
----------------------------------------------------------------------------------------------------------------On 
Tue, 27 Nov 2012 11:04:39 +0000, Gallagher Susan (COUNTESS OF CHESTER 
HOSPITAL NHS FOUNDATION TRUST) wrote 
Good Afternoon,  
   
I have today come across your paper 'Psychometric evaluation of a new instrument to 
measure disease self-management of the early stage chronic kidney disease patients'.  
    
Similar to my email correspondence yesterday regarding the CKD-SE scale- I wonder is it 
possible that I may use this questionnaire in my Master degree dissertation? Is there any 
permissions/licences I am required to get in order to use it? And is there a 'patient friend' 
version of the scale for use?  
    
Kind Regards  
Susan  
 
Susan Gallagher  
Dietitian   
    
Countess of Chester Hospital NHS Foundation Trust  
Countess of Chester Health Park  
Liverpool Road  
Chester  
Cheshire  
CH2 1UL  
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Appendix 9 Researcher-administered questionnaire 
 
 
 
 
 
 
 
For Completion by the Researcher (from patient medical records) 
 
Diabetes diagnosed (MM/YY)…………………………………………………………. 
 
Diagnosed with Diabetic Nephropathy (MM/YY)………………………………….. 
(Assessed by date of first abnormal microalbuminuria as documented in medical records) 
 
Medication and doses 
Diabetes medications 
_________________________________________________________ 
_________________________________________________________ 
_________________________________________________________ 
 _________________________________________________________ 
 
Anti-hypertensive medications 
_________________________________________________________ 
_________________________________________________________ 
_________________________________________________________ 
 _________________________________________________________ 
 
Dyslipidaemia medications 
_________________________________________________________ 
_________________________________________________________ 
_________________________________________________________ 
 _________________________________________________________ 
 
Does the participant have other complication of diabetes? 
Retinopathy 
Neuropathy 
Cardiovascular disease 
Peripheral vascular disease 
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Biomedical Results 
 
Glycated Haemoglobin (HbA1c)    __________ mmol/mol 
Estimated Glomeular Filration Rate (eGFR) __________ ml/min/1.73 m2 
Miroalbuminuria (MCACR) (if applicable) __________ mg/mmol 
Proteinuria (Urine Prot/Cr) (if applicable)  __________ mg/mmol 
Total Cholesterol     ___________ mmol/L 
HDL Cholesterol     ___________ mmol/L 
LDL Cholesterol     ___________ mmol/L 
Total/HDL ratio     ___________  
Triglycerides      ___________ mmol/L 
Blood Pressure     ___________ mm Hg 
Height       ___________ m 
Weight      ___________ kg 
Body Mass Index     ___________ kg/m² 
 
 
 
Questionnaire complete             Complete     Not Complete 
Pre intervention knowledge questionnaire   
Pre-intervention self-efficacy questionnaire   
Pre-intervention self-management questionnaire  
 
Post-intervention knowledge questionnaire   
Post-intervention self-efficacy questionnaire  
 
 
Patients preferred method of participating in qualitative research  
Face to Face appointment with research at COCH Diabetes Unit 
Postal questionnaires 
Telephone questionnaires 
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Appendix 10 Baseline data questionnaire 
 
 
 
 
 
 
About You 
 
 
Participant Number:   
 
Gender  Male    Female  
 
 
Date of Birth _______/______/_______ 
 
White 
 
British 
Irish 
Any other White background 
 
Mixed 
 
White and Black Caribbean 
White and Black African 
White and Asian 
Any other mixed background 
Asian or Asian British 
 
Indian 
Pakistani 
Bangladeshi 
Any other Asian background 
Black or Black British 
 
Caribbean 
African 
Any other Black background 
Other Ethnic Groups 
 
Chinese 
Any other ethnic group 
 
Highest level of education: 
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1-4 O Levels, CSEs, GCSEs (any grade), Entry Level, Foundation Diploma 
NVQ Level 1, Foundation GNVQ, Basic Skills 
5+ O Levels (passes), CSEs (grade 1), GCSEs (grades (A*-C), School Certificate, 1 
A level, 2-3 AS levels, VCEs, Higher Diploma 
NVQ  Level 2, Intermediate GNVQ, City and Guilds Craft, BTEC First/General 
Diploma, RSA Diploma  
Apprenticeship  
2+ A levels/VCEs, 4+AS levels, Higher School Certificate, Progression/Advanced 
Diploma  
NVQ Level 3, Advanced GNVQ, City and Guilds Advanced Craft, ONC, OND, 
BTEC National, RSA Advanced Diploma  
Degree (for example BA, BSc), Higher degree (for example MA, PhD, PGCE) 
NVQ Level 4-5, HNC, HND, RSA Higher Diploma, BTEC Higher Level  
Professional qualifications (for example teaching, nursing, accountancy) 
Other vocational/work related qualifications 
Foreign qualifications 
No qualifications 
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Employment Status 
Working full time (35 + hours per week) 
Working part time 
Unemployed 
Retired/Disability 
Homemaker 
Student 
Other, specify……………………… 
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About your Diabetes   
Which type of Diabetes do you have?         Type 1    Type 2  
 
 
 
Diabetes Medication (Please tick all that currently apply to you) 
 No medication, diet and lifestyle only 
 Tablets (e.g. Metformin, Gliclazide, Pioglitazone, Sitagliptin) 
 Incretin Mimetic (Exenatide (Byetta/Bydureon) or Liraglutide (Victoza)) 
 Insulin 
 
 
Do you have any other complication of diabetes? 
Retinopathy (damage to eyes)  
Neuropathy (nerve damage) 
Cardiovascular disease (affecting the heart)  
Peripheral vascular disease (affecting the limbs usually the feet)  
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Previous Diabetes Education  
 
Have you received diabetes education in the past? 
 
        Yes      No  
 
If yes, which of the following bests describe the education you have received?  
(Please tick all that apply to you) 
 
 One to one education with a health professional e.g Doctor/Nurse/Dietitian  
Diabetes Essentials 
Other generally diabetes education session (e.g. X-PERT programme, DESMOND, 
or other education session)  
Carbohydrate counting and insulin dose adjustment education (e.g. DISC, DAFNE 
or other carbohydrate and insulin dose adjustment education sessions)  
 Other education, please specify……………………………………… 
 
How long did this education last? 
Less than 15 minute 
15-30 minutes 
30-60 minutes 
1-3 hours 
Multiple sessions over a number of days/weeks  
 
How long ago did you have this education? (Where you have had more than one type 
of education please indicate the time since the most recent education) 
In the past six months 
Within the previous year 
1-2 years ago 
2-5 years ago 
Greater than 5 years ago 
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Appendix 11 Participant questionnaire: CKD-SM 
 
 
 
 
 
 
 
Chronic Kidney Disease Self-Management Questionnaire 
 
The following statements relate to how you manage your chronic kidney 
disease (CKD) 
 
 
Please choose a number on a scale of 1 to 4 of how often you feel you 
do the task described in each question where: 
 
1 = Never   2 = Rarely    3 =Often  4 = Always 
 
 
There is no right or wrong answer, just answer how you feel currently in 
relation to the statements. 
 
 
 
 
Please answer each question (1 -29) 
 
 
 
 
 
If you have any questions please ask  
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Read each statement and decide how often you do that activity where 
1= Never 2= Rarely  3=Often 4 = Always 
 
In relation to your kidney disease how often do you…. 
 
 
1. Pay attention to habits that may affect kidney function  
e.g. your medication; your salt intake; your diabetes control; your 
weight; your physical activity levels              
              1  2  3  4 
 
2. Adjust your food portions and choices when you are eating out, 
meeting friends or attending celebrations 
e.g. choosing low fat or low salt foods when possible; eating smaller 
portions of foods that are high in fat or salt; keeping to portion sizes that 
are appropriate for you 
 
              1    2        3       4 
 
 
3. Give up habits harmful to the kidneys 
e.g. regular intake of high salt, high fat foods, high alcohol intake, 
sedentary lifestyle 
 
              1  2  3  4 
 
 
4. How often do you think about giving up smoking? 
 
Non applicable          1  2  3  4 
 
 
5.  How often have you attempted to give up smoking? 
 
Non applicable           1      2  3  4 
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Read each statement and decide how often you do that activity where 
1= Never 2= Rarely  3=Often 4 = Always 
In relation to your kidney disease how often do you…. 
 
 
 
6. Adjust the things you do to look after your kidneys to fit different 
situation  
Examples of different situation include when on holiday, eating out or 
away from home or socialising with family/friends. Examples of things to 
adjust may include: when to take your medication; how to accommodate 
exercise; choose low fat or salt meals and snacks; eat a smaller portion 
size than is served; take suitable food with you; research options before 
you travel 
 
              1  2  3  4 
 
 
 
7. Choose food options to avoid harming your kidneys  
e.g. choose low salt foods; reduce the amount of foods high in simple 
sugars; choose low fat foods; choose healthy portion sizes 
 
              1  2  3  4 
 
 
 
8. Manage CKD (Chronic Kidney Disease) to stay healthy 
e.g. know your blood and urine results and take steps to improve 
results, if needed; take your medication as advised by your medical 
team; aim for or maintain a healthy weight; take regular exercise; make 
choices to keep to a healthy diet 
 
              1  2  3  4 
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Read each statement and decide how often you do that activity where 
1= Never 2= Rarely  3=Often 4 = Always 
 
In relation to your kidney disease how often do you…. 
 
 
9. Fit the things you need to do to look after your kidneys into your 
daily life 
e.g. taking your medication as prescribed, reduce the amount of salt or 
saturated fat in your meals; improve your diabetes control; ensure you 
are regularly physically active; aim for or maintain a healthy weight 
 
              1  2  3  4 
 
 
 
10. Adjust your lifestyle to maintain kidneys in the best condition 
e.g. ensure time is available for regular physical activity; improve your 
diabetes control if necessary; change the foods you eat in order to 
choose low salt options; if you are overweight make attempts to lose 
weight 
 
              1  2  3  4 
 
 
 
11. Participate selectively or avoid certain social activities 
examples of social activities: going to the pub or other situations where 
drinking alcohol is anticipated; eating takeaways or eating out; 
functions/activities where snacking is expected e.g. cinema, parties; 
avoiding situations where smoking is anticipated 
 
              1  2  3  4 
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Read each statement and decide how often you do that activity where 1= 
Never 2= Rarely  3=Often 4 = Always 
In relation to your kidney disease how often do you…. 
 
 
12. Change lifestyle to avoid worsening of kidney function 
e.g. avoid smoking; avoid high salt foods; include exercise regularly; 
make changes to aim to keep to a healthy weight; ensuring advice on 
medication is followed              
              1  2  3  4 
 
 
 
13. Actively seek information about kidney disease 
e.g. information on: what kidney disease is, what you can do to help 
control it 
 
              1  2  3  4 
 
 
 
14. Actively seek resources to better control CKD (Chronic Kidney    
Disease) 
e.g. advice on how to reduce your salt intake or advice on how to 
reduce your fat intake or your overall eating habits in relation to kidney 
disease advice; seek guidance on how to improve your diabetes control; 
information on the medication you use 
 
              1  2  3  4 
 
 
 
15. Use different ways to clarify questions about your treatment 
plan 
e.g. talking to your GP, Diabetes Specialist Nurse or other members of 
your diabetes or kidney specialist team; getting information from patient 
information booklets, internet resources or attending patient meeting 
groups such as your local Diabetes UK group; talking to other people 
with the condition 
 
              1  2  3  4 
 
Read each statement and decide how often you do that activity where 
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1= Never 2= Rarely  3=Often 4 = Always 
 
In relation to your kidney disease how often do you…. 
 
 
16. Use different ways to solve problems 
e.g. talking to your GP, nurse or other members of your medical 
team; asking for advice on issues that matter to you in relation to 
your diabetes or kidney disease; identifying problems that you may 
have and identify how you can make changes; asking family or 
friends for help with solving problems; looking for information or 
support groups to help solve problems 
 
              1  2  3  4 
 
 
 
17. Find out reasons for signs and symptoms of CKD (Chronic 
Kidney Disease) 
e.g. talking to your GP, Diabetes Specialist Nurse or other members 
of your diabetes or kidney specialist team; getting information from 
patient information booklets or internet sites 
 
              1  2  3  4 
 
 
 
18. Think about reasons for your abnormal blood or urine 
results 
              1  2  3  4 
 
 
 
19. Find out possible reasons for your High Blood Pressure 
result 
              1  2  3  4 
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Read each statement and decide how often you do that activity where 
1= Never 2= Rarely  3=Often 4 = Always 
In relation to your kidney disease how often do you…. 
 
 
20. Ask the meaning of your blood and urine test results  
              1  2  3  4 
 
 
 
21. Seek to understand your risk factors of CKD (Chronic Kidney 
Disease) e.g. your blood pressure, your diabetes control, etc. 
 
              1  2  3  4 
 
 
 
22. Share your experience with other patients 
              1  2  3  4 
 
 
 
23. Share feelings of helplessness or frustration with other 
patients  
              1  2  3  4 
 
 
 
24. Ask your family or friends for help when you feel helpless or 
frustrated  
              1  2  3  4 
 
 
 
25. Discuss questions or worries you have with family or friends  
            
              1  2  3  4 
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Read each statement and decide how often you do that activity where 
1= Never 2= Rarely  3=Often 4 = Always  
In relation to your kidney disease how often do you…. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please place the finished questionnaire in the envelope provided 
 
 
 
 
26. Tell your family or friends about your CKD (Chronic Kidney 
Disease) treatment plan  
              
              1  2  3        4 
 
 
 
27. Follow health care professional’s suggestion to adjust your 
dietary habits e.g. follow a low salt diet,  reduce your intake of 
saturated fat or follow a low potassium diet if advised 
 
              1  2  3  4 
 
 
 
28. Follow health care professional’s suggestion to control your 
weight 
              1  2  3  4 
 
 
 
29. Follow health care professional’s suggestion to exercise 
          
              1  2  3  4 
  
 
 
30. Follow the dieticians’ suggestion on choosing food 
           
              1  2  3  4 
 
150 
 
Appendix 12 Participant questionnaire: CKD-SE 
 
 
 
 
 
 
Chronic Kidney Disease Self Efficacy questionnaire 
 
The following statements relate to how confidently you feel about your 
management of 
Chronic Kidney Disease CKD 
 
Please choose a number on a scale of 1 to 10 of how confident you feel 
where 
0 means not confident 
and 
10 means extremely confident 
 
Circle a number on the scale for each question 
0 = Not confident                        10= Extremely Confident  
 
 
  0       1       2        3         4          5         6        7         8          9          10 
  |_____|____|____|_____|_____|_____|_____|_____|______|_____|   
 
There is no right or wrong answer, just answer honestly about how you feel. 
 
Please answer each question (1 – 25) 
 
 
If you have any questions please ask  
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Please circle a number on each scale in response to the question 
 
   0 = Not confident      10= Extremely Confident 
 
 
1. I am comfortable telling others that I suffer from Chronic Kidney 
Disease (CKD) 
 
    0         1           2         3         4          5         6         7          
8           9          10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____|  
 
 
 
 
2. I can actively seek out information that explains the CKD related signs 
and symptoms (like high blood pressure, protein in my urine, and fluid 
retention etc). 
 
    0         1           2         3         4          5         6         7          
8           9          10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____|  
 
 
 
 
3. I can understand the meaning of the CKD-related blood and urine 
results. 
 
    0         1             2         3         4          5         6         7          
8           9          10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____|  
 
 
 
 
4. I can accept the fact that I suffer from chronic kidney disease. 
 
    0         1           2         3         4          5         6         7          
8           9          10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____|  
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Please circle a number on each scale in response to the question 
 
0 = Not confident                    10= Extremely Confident 
 
 
5. I understand the risk factors associated with CKD, like high blood 
pressure, diabetes, drugs etc. 
 
  0      1       2     3     4      5     6      7     8      9       10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____|  
 
 
 
 
6. I would be able to discuss my worries with my family or friends for 
solutions. 
 
0      1       2     3     4      5     6      7     8      9       10     
|_____|______|_____|_____|_____|_____|_____|_____|______|_____|  
 
 
 
 
7. I would seek help whenever I am stressed out by work or family matters 
so that it would not affect my disease. 
 
 0      1      2      3     4     5     6      7     8      9      10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
8. I would actively seek out necessary precautions to prevent my CKD 
from worsening. 
 
  0     1      2      3     4      5     6     7      8      9      10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
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Please circle a number on each scale in response to the question 
 
0 = Not confident                    10= Extremely Confident 
 
 
9. I am willing to share my experience of self-managing CKD with other 
patients. 
 
0      1       2      3      4    5     6     7      8      9       10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
10. I would be able to adjust my management (e.g. food consumption, 
amount of activity, and medication etc.) of my CKD to fit different 
situations (like travelling or during festivities or celebrations etc.). 
 
 0     1       2      3     4      5     6     7      8      9      10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
11. I am comfortable asking health care professionals about my current 
medical conditions 
   0    1      2     3     4     5      6     7      8      9      10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
12. I can face the challenges of living with CKD  
 
 0     1       2     3     4      5     6     7      8       9     10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
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Please circle a number on each scale in response to the question 
 
   0 = Not confident             10=Extremely Confident 
 
 
13. I can actively seek out resources for better control of my CKD  
       e.g. advice on eating habits; guidance on diabetes control; information on 
the medication you use 
 
 0     1       2      3     4      5     6     7     8       9     10 
    |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
14. I can actively tell my family and/or friends about my CKD treatment 
plans (like diet control and medication etc.) to gain their support. 
 
 
  0      1      2     3      4    5      6     7      8      9      10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
15. I would be able to control my diet, even if I am attending a wedding or 
celebration, in order not to increase the workload on my kidney. 
 
 0      1       2      3    4      5     6     7      8       9     10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
16. I would be able to manage my CKD as I am maintaining my health. 
 
  0     1        2     3     4      5     6      7     8      9     10 
      |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
17. I would take the initiative to tell any doctors looking after me that I am 
suffering from CKD. 
 
 0      1        2        3         4          5         6         7          8           
9          10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
Please circle a number on each scale in response to the question 
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   0 = Not confident              10=Extremely Confident 
 
 
18. I would take the initiative to ask my doctor for advice whenever any 
questions about my medications occur to me. 
 
      0         1           2         3         4          5         6         7          
8           9          10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
19. I would be able to choose the type and amount of food appropriate to 
my disease when participating in social activities. 
 
      0         1           2         3         4          5         6         7          
8           9          10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
20. I would be able to look for information related to CKD through various 
channels (e.g. Internet, flyers, magazines, newspapers). 
 
     0         1           2         3         4          5         6         7          
8           9          10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
21. I would take the initiative to contact the healthcare professionals 
looking after me for advice whenever any questions about my disease or 
treatment occur to me, even without a scheduled appointment.  
 
      0         1           2         3         4          5         6         7          
8           9          10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
 
 
 
Please circle a number on each scale in response to the question 
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   0 = Not confident             10=Extremely Confident 
 
 
22. I would be able to adhere to the diet restrictions recommended by the 
healthcare professionals. 
 
 0      1       2     3      4     5     6     7      8      9      10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
23. I would be able to adjust my dietary habits in accordance with the 
recommendations of the dietitians or health care professionals. 
 
   0     1       2     3     4     5      6     7     8       9      10 
      |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
24. I would selectively participate in social activities (e.g. attending 
dinners or gatherings) in order to control of my CKD. 
 
 0      1       2     3    4       5     6     7     8       9      10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
 
25. I can actively seek help from my family or friends whenever I am 
feeling depressed or frustrated with my CKD 
 
  0      1      2     3      4    5      6    7      8       9      10 
     |_____|______|_____|_____|_____|_____|_____|_____|______|_____| 
 
 
 
Thank you for taking the time to complete this questionnaire. 
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Appendix 13 Participant questionnaire: KiKS 
 
 
 
 
Kidney Disease Knowledge Survey  
 
Please tick the box next to the answer you think is correct  
 
1. On average, your blood pressure should be: 
 160/90 
 150/100  
 170/80  
 Lower than 130/80 
 
2. Are there certain medications your doctor can prescribe to help keep 
your kidneys as healthy as possible? 
 
 Yes     No 
 
3. Why is too much protein in the urine not good for the kidney? 
It can scar the kidney 
  It is a sign of kidney damage 
It is a sign of kidney damage and can scar the kidney 
It can cause an infection in the urine 
All of the above 
4. What does GFR stand for? 
Glomerular Filtration Rate- tells us level of kidney function  
Good Flow Renal- tells us about flow of urine from kidneys 
Gain for Real- tells us if your kidney function is improving 
Glucose Function Rate- tells us about your blood sugar level 
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5. Are there stages of CHRONIC kidney disease? 
 Yes     No  
 
6. Does Chronic Kidney Disease increase a person’s chances of a heart 
attack? 
 Yes     No  
 
7. Does Chronic Kidney Disease increase a person’s chance for death 
from any cause? 
 Yes     No 
 
8. This section is about WHAT THE KIDNEY DOES. 
 Please select one answer to each question below.  
               Yes    No 
Does the kidney make urine? 
Does the kidney clean blood? 
Does the kidney help keep bones healthy? 
Does the kidney keep a person from losing their hair? 
Does the kidney help keep red blood cell count normal? 
Does the kidney help keep blood pressure normal? 
Does the kidney help keep blood sugar normal? 
Does the kidney keep potassium levels in the blood normal? 
Does the kidney keep phosphorus levels normal? 
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Appendix 14 Qualitative interview schedule 
 
 
 
 
 
 
 
Qualitative Interview Schedule for structured interviews (Contact 3) 
 
1) Please can you tell me about your overall opinion of the education session? 
 
2) In your opinion, what are the key messages you took from the session? 
 
3) Please can you tell me in what ways the session helped you? 
 
4) Could you please tell me about any changes in your lifestyle you have made since 
attending the course? 
 
5) Are there any other changes that you intend to make or would like to make? 
 
6) What do you see as the benefits to making the lifestyle changes suggested? 
 
7) Are there any disbenefits to making the lifestyle changes? 
 
8) Can you tell me what has helped you in making lifestyle changes? 
 
9) Can you tell me what has hindered you in making lifestyle changes? 
 
10) In your opinion, is there any further advice or support that would be helpful to you at 
this stage? 
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Appendix 15 Research Bursary: Cheshire & Wirral Partnership 
NHS Foundation Trust  
 
Dear Susan, 
  
I'm pleased to say that your research bursary has been approved, and can be invoiced for in April, from 
CWP. 
  
I hope all is progressing well, and please let me know if you have any queries. 
  
Best wishes, Phil 
  
Dr Phil Elliott 
Senior Research Facilitator 
Cheshire and Wirral Partnership NHS Foundation Trust  
and NHS Western Cheshire 
1829 Building 
Countess of Chester Health Park 
Liverpool Road 
CHESTER 
CH2 1HJ 
 
 
 
From: Gallagher Susan (COUNTESS OF CHESTER HOSPITAL NHS FOUNDATION TRUST)  
Sent: 11 March 2013 15:18 
To: Phil Elliott 
Subject: Bursary Application: A modular approach to diabetes structured group education 
Dear Dr. Elliot  
Please find attached an application for a bursary to develop and carry out research within Cheshire, 
Warrington and Wirral.  
In brief, the project is entitled "A modular approach to diabetes structured group education: The effects of 
Diabetes Essentials: Kidneys on patient knowledge, self-efficacy, self-care behaviour and patient experience 
in diabetic kidney disease". 
The project aims to determine the effects of structured group education for patients and will be carried out at 
the Diabetes Unit at the Countess of Chester NHS Foundation Trust. It will involve patients from Western 
Cheshire Clinical Commissioning Group. The project has received approval from NHS National Research 
Ethics Committee and the Countess of Chester NHS Foundation Trust.  
Should you have any questions, please contact me by email or on  
Yours sincerely  
Susan  
Susan Gallagher 
Dietitian  
  
Countess of Chester Hospital NHS Foundation Trust 
Countess of Chester Health Park 
Liverpool Road 
Chester 
Cheshire 
CH2 1UL 
******************************************************************************** 
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Appendix 16 A Research Bursary: Cheshire and Merseyside 
Allied Healthcare Professional Application showing travel 
expenses reimbursement  
  
COST JUSTIFICATION (500 words) 
The transcription cost for twelve structured interviews amounts to £490. 
Qualitative research will be employed in order to gain understanding about the 
patient experience of education and its impact on their self-care practices, whilst 
also aiding understanding of the relationship between the reported quantitative 
outcome measures. This will assist in assessing the multi-factorial approach 
required for the management of this chronic disease. The qualitative interviews will 
be entirely voice recorded. The cost associated with transcribing the audio 
recording is £490.  
 
Cost of travel: All reasonable cost of travel will be reimbursed to research 
participants. This will be provided at a rate of £0.40/mile. 
 
Planning for travel from the boundaries of Western Cheshire Clinical Commission 
Group boundaries to the study venue is approximately 17 miles, each way. A 
return journey would cost £13.60 and with participants expected to attend three 
visits over the duration of the study this would result in a cost of £40.80/participant. 
Minimum recruitment is anticipated as twelve people. Therefore travel expenses 
(12 participants with 3 journeys at £13.60/visit) are estimated as £489.60.  
 
Cheshire and Merseyside 
Allied Health Professions 
(AHP)  
Research Network 
 
Research Bursary 
Application Form 
 
Cheshire & 
Merseyside
Allied 
Health 
Professions
Research 
Network
 
TOTAL COSTS REQUESTED (Must not exceed £1000 – direct costs) 
Transcription cost for twelve structured interviews: £490 
Payment of public expenses: £489.60  
 
Total Requested: £979.60 
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Appendix 16 B Research Bursary: Cheshire and Merseyside 
Allied Healthcare Professional Invoice  
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Appendix 17 Research Bursary: Lily Grants & Donations  
 
10th May 2013 
 Susan Gallagher 
Diabetes Research Dietitian 
Countess of Chester Hospital NHS Foundation Trust 
Liverpool Road 
Chester 
CH2  1UL 
   
Dear Susan,  
  
Re: Grant/Donation Application 
I am pleased to inform you that the Lilly Grants and Donations Committee have approved a grant 
to Countess of Chester Hospital NHS Foundation Trust for the sum of £4,000 towards your project 
looking at a modular approach to diabetes structured group education.  Please provide full bank 
details of Chester Hospital on headed paper so a bank transfer can be arranged. 
If the entire grant/donation sum is not used, please contact me to arrange for the return of these 
unused funds to Lilly UK. If you have any questions, please call the Lilly UK switchboard on 01256 
315000 and ask to speak to the Grants and Donations Committee Secretary. 
  
Lilly’s decision to grant you funding  is not  intended to, and should not,  influence the decision of 
any person or  institution to purchase and/or prescribe Lilly medicines or otherwise  influence any 
future  or  pending  business  with  Lilly.  We  require  that  Countess  of  Chester  Hospital  NHS 
Foundation Trust comply with all applicable UK & US anti‐bribery  laws. Lilly hereby confirms that 
our decision to grant you funding has been made on the understanding that Countess of Chester 
Hospital NHS Foundation Trust will not give or promise to give, and will not make, offer, agree to 
make  or  authorize  any  payment  or  transfer  anything  of  value,  directly  or  indirectly,  (i)  to  any 
Government  or  Public  Official;  (ii)  any  political  party,  party  official  or  candidate  for  public  or 
political office; (iii) any person while knowing or having reason to know that all or a portion of the 
value will be offered, given, or promised, directly or indirectly, to anyone described in items (i) or 
(ii) above; or (iv) any owner, director, employee, representative or agent of any actual or potential 
customer of Lilly in consequence of it.  Additionally, we require that Countess of Chester Hospital 
NHS Foundation Trust take no action that might cause Lilly to be in violation of any applicable UK 
& US anti‐bribery laws. 
  
If any of the above is unacceptable to you, then, please contact the Secretary of the Lilly Grants 
and Donations Committee on   or at the address at the head of this letter and we shall 
withdraw the grant offer. 
  
 Yours sincerely, 
Grants and Donations Committee
 Lilly UK  
Lilly House, Priestley Road 
Basingstoke, Hampshire, RG24 9NL 
UNITED KINGDOM 
Tel: +44 (0)1256 775042 Fax: +44 (0)1256  
775858  
www.lilly.co.uk 
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Appendix 19 “Diabetes Essentials: Kidneys” module 
information  
‘Diabetes Essential’ is a package of structured diabetes group education provided by the 
Countess of Chester Hospital NHS Foundation Trust and commissioned by the Western 
Cheshire Clinical Commission Group. This education package is a tiered approach to the 
provision of education, grounded by the basic education (Diabetes Essentials), and 
building on this with more intensive specialist education for the complication of diabetes 
e.g. Diabetes Essentials: Kidneys; Diabetes Essentials: Foot and it also facilitates the 
specialist needs of specific sub-populations e.g. Gestational diabetes (Diabetes 
Essentials: GDM) and carbohydrate counting and insulin dose adjustment (Diet and Insulin 
dose adjustment at the Countess, [DISC]).  
 
‘Diabetes Essentials: Kidneys’ is a complication specific module targeting patients with 
DKD, delivered as a two hour group session at the diabetes specialist unit of the Countess 
of Chester Hospital NHS Foundation Trust. It aims to provide patients with the knowledge, 
skills and confidence to advance their management practices in view of their condition.  
 
Topics to be delivered in this education course are based on NICE guidelines (NICE, 
2004; NICE, 2008; NICE, 2008) and nationally recognised evidenced based nutritional 
guidelines for the management of diabetes (Dyson, et. al., 2011) and incorporation of 
aspects of clinical care identified as appropriate and necessary by the multi-disciplinary 
team with interest in DKD. 
 
The multi-disciplinary team comprised of Consultants in Endocrinology and Diabetology, a 
DSN with special interest in DKD, a renal specialist nurse and diabetes and renal 
specialist dietitans. This multi-disciplinary approach help ensured all relevant 
recommendations and information were included. The views and opinions of lay persons 
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with diabetes were also considered through consultation with the local Diabetes UK 
voluntary group.  The emphasis is on empowering patients by explaining medical 
terminology, interpreting test results and encouraging participation in self-care, thereby 
promoting a shared care approach to the condition. Advice on anti-hypertensive 
medication, diet and lifestyle are combined with this in order to enable patients to self-
manage their condition and to re-enforce advice they may have had previously. 
 
The learning outcomes of the session agreed were to: 
• Promote awareness of what kidneys do 
• Increase understand of how diabetes affects your kidneys 
• Increase ability to interpret urine and blood tests results specific to the condition 
• Improve understand of the effects of kidney disease 
• Understand the importance of good blood pressure control 
• Highlight the importance of medication coherence  
• Increase knowledge on the effects of diet and lifestyle on kidney health 
 
The session was deliver in consideration of adult learning principles (Knowles 1984), using 
a mixture of teaching styles which were identified as preferential learning styles by the 
local Diabetes UK voluntary group. This involved the use of physical visual aids combined 
with animations to describe kidney function; food models and food label to encouraged 
discussion, learning and practical skills with regards to food choices; and quizzes to 
emphasis important element with regards to the benefits of management and medication 
usage. 
 
 
 
 
